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ABSTRACT
RECOMBINANT EXPRESSION AND POTENTIAL AUTOCATALYSIS OF
AEDES AEGYPTI TRYPSIN-LIKE SERINE PROTEASES (AASPII AND AASPIV)
by Diane Eilerts
Aedes aegypti mosquitoes can be found globally in tropical and subtropical urban
areas and spread Zika, Dengue fever, yellow fever, and Chikungunya viruses. Current
vector control methods are limited and nonspecific. The female Ae. aegypti mosquito
uses blood meal proteins to obtain nutrients required for oogenesis; inhibition of the
midgut trypsin-like serine proteases responsible for blood meal digestion may provide a
novel method of vector control. Ae. aegypti blood meal digestion is complex and the role
of uncharacterized serine proteases in blood digestion is unclear; specifically, a group of
trypsin-like serine proteases (AaSPII–V) is expressed at constant levels before and
following Ae. aegypti blood meal acquisition. This research focuses on the in vitro
biochemical study of two specific Ae. aegypti trypsin-like serine proteases (AaSPII and
AaSPIV) in order to gain further understanding of their role in blood meal digestion. The
approach involved the successful cloning and bacterial expression of these soluble,
recombinant proteases. Results from attempts to purify these proteases were unsuccessful
but indicative of potential autocatalytic and autodigestive behavior. Future studies will
focus on obtaining purified recombinant proteases for further study. The study of AaSPII
and AaSPIV, as well as other midgut Ae. aegypti proteases, will aid in understanding the
overall role proteases play in blood meal digestion and may eventually allow for the
development of mosquito-specific enzyme inhibitors.
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CHAPTER 1: INTRODUCTION
1.1 Role of Aedes aegypti in Viral Pathogen Transmission
Aedes aegypti mosquitoes have a complex life cycle with both aquatic and terrestrial
stages (Figure 1).1 Adult female mosquitoes lay eggs in the walls of water-filled
containers above the water’s surface.1 Even small amounts of water are sufficient for
attracting female mosquitoes and eggs can survive desiccation and remain viable through
cold and dry conditions for several months.1 Once the water level rises to cover the eggs,
larvae emerge and feed on microorganisms present in the water. The larvae molt 3 times
before transforming into pupae and continue to develop in the water.1 Adult flying
mosquitoes (imago) emerge from pupal skin and leave the water environment.1 Both
male and female mosquitoes feed on nectar, but only female mosquitoes require blood for
egg production and after obtaining a blood meal will seek out water sources for an ideal
environment to lay eggs.1
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Figure 1. The Ae. aegypti life cycle showing aquatic and terrestrial stages. Female
mosquitoes lay eggs in the walls of water-filled containers. When eggs are covered with
water, larvae emerge. Larvae eventually transform into pupae and develop into adult
mosquitoes. Public domain image by Mariana Ruiz Villarreal.
Ae. aegypti mosquitoes act as vectors of the viral pathogens Zika, Dengue fever,
yellow fever, and Chikungunya viruses, which can cause numerous human diseases.2
When mosquitoes acquire a blood meal from an infected host, they too become infected;
after an incubation period in which the pathogen can develop and replicate within
mosquitoes, they can transmit these pathogens to a new host during later blood meal
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acquisition.2 Humans remain the primary amplifying host for such viruses.3 Several
factors are thought to contribute to the anthropophilic nature of Ae. aegypti mosquitoes.
Research suggests that the evolution of Ae. aegypti mosquitoes to preferentially feed on
humans may be linked to increases in the expression and ligand-sensitivity of a specific
odorant receptor for sulcatone, an odorant primarily associated with humans.4 Feeding on
humans (as opposed to primates or other vertebrates) benefits mosquito fitness for several
reasons: (1) humans are hairless, making it easier to obtain a blood meal, (2) humans
have a tendency to live in large groups, making food sources abundant for mosquitoes,
and (3) humans typically provide adequate environments for mosquito eggs by collecting
water, storing water, and producing debris that collects water.4 Therefore, feeding
preferentially on humans may provide Ae. aegypti mosquitoes with greater reproductive
fitness. Ae. aegypti mosquitoes live and thrive in tropical, subtropical, and temperate
urban and semi-urban areas.3 Due to its anthropophilic nature, tendency to bite multiple
times before oogenesis completion, and propensity to live in highly populated areas, the
Ae. aegypti mosquito is a highly efficient vector.3
1.1.1 Zika
The Zika flavivirus (ZIKV) is primarily transmitted by infected Ae. aegypti mosquitoes;
however, sexual transmission of ZIKV has also been reported.5,6 There is currently no
vaccine available but symptoms are typically mild, usually lasting for 2 to 7 days and
consisting of fever, rash, conjunctivitis, pain, malaise, and headache.5 Additionally, Zika
infection in pregnant women has recently been associated with various birth defects in
offspring including microcephaly and Guillain-Barré syndrome.7,8 Microcephaly is a birth
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defect causing a baby’s head to be much smaller in size than expected.9 Microcephaly
occurs when a baby’s brain does not develop properly during pregnancy or stops growing
after birth. Several problems can be associated with microcephaly, including seizures,
developmental delays, intellectual disability, problems swallowing, hearing loss, and
vision issues. Severity ranges but problems are typically lifelong and often life
threatening.9 Guillain-Barré syndrome is a disorder in which the body’s immune system
attacks the peripheral nervous system; it is the most severe acute paralytic neuropathy
and consists of several variants.10 Up to 30% of all cases manifest as severe GuillainBarré syndrome with respiratory failure. Initial symptoms include weakness and tingling
in extremities and can quickly worsen, leading to paralysis. While most people recover
from Guillain-Barré syndrome, some people experience continued symptoms.10 There is
no cure for microcephaly or for Guillain-Barré syndrome.9,10 Zika virus is endemic in
several areas within Africa and Asia (Figure 2).5 More recently, locally acquired Zika has
also been reported in the Americas and even in the continental United States in Florida
and Texas (Figure 3).5,11
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Figure 2. Global Distribution of Zika virus transmission. Figure obtained from the Centers for Disease Control and Prevention.
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Figure 3. Distribution of Zika virus in the United States. Laboratory-confirmed Zika virus disease cases by state as of January
11, 2017. Degree of shading indicates density of cases reported. Figure obtained from the Centers for Disease Control and
Prevention.

6

1.1.2 Dengue
Dengue virus (DENV) is an RNA flavivirus consisting of five serotypes (DEN-1,
DEN-2, DEN-3, DEN-4, and the recently discovered DEN-5) primarily transmitted by
Ae. aegypti mosquitoes.3,12 Dengue fever, which can result from infection by DENV,
causes flu-like symptoms (fever, headache, severe pain, rash, bleeding) and has potential
to develop into severe dengue (or Dengue Hemorrhagic Fever), a lethal complication
characterized by massive bleeding and shock.13 There is extensive genetic variability
among the five serotypes, making vaccine development challenging.13 Because the virus
has multiple serotypes, those who recover from dengue fever and gain immunity to a
particular serotype can still fall victim to subsequent infection by another serotype;
unfortunately, consecutive dengue infection by multiple virus serotypes increases the risk
of severe dengue.13
Because dengue cases are severely underreported and often misdiagnosed, actual
dengue infection incidence cannot be accurately determined.13 A 2012 study estimates
that approximately 3.9 billion people in 128 countries are at risk of dengue infection.14
Furthermore, a 2013 estimate suggests that approximately 390 million dengue infections
occur annually, with approximately 96 million manifesting clinical symptoms.15 Cases of
imported dengue infections have been reported throughout Mexico and the United States;
instances of locally acquired dengue confirmed by the CDC have occurred in Florida,
Texas, Hawaii, and even New York.16 Increasing air travel and globalization will
continue to impact the distribution of dengue throughout the United States, especially in
southern border states like California, Arizona, and Texas (Figure 4).16
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Figure 4. Distribution of Dengue in the United States. Shading indicates regions of imported and/or locally acquired dengue
cases in the United States confirmed by the CDC between 2010 and 2014. Values indicate the number of imported dengue
cases reported and locally acquired cases (parentheses) reported. Hashed area represents areas at risk based on 2013 vector
distribution estimates. Reprinted with permission from Fredericks and Fernandez-Sesma16; DOI:
http://dx.doi.org/10.1016/j.aogh.2015.02.006 in accordance with Creative Commons user license:
https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.
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1.1.3 Yellow Fever
The yellow fever flavivirus (YFV) is another viral pathogen transmitted by infected
Ae. aegypti mosquitoes. Fever, headache, jaundice, pain, nausea, vomiting, and fatigue
are symptoms of yellow fever infection.17 Yellow fever virus is endemic in tropical
regions of Africa as well as in Central and South America (Figures 5 and 6).17 While
most patients see symptoms disappear within 3 to 4 days, a small portion of those
infected succumb to a second, more toxic phase following the initial recovery in which
high fever, jaundice, and bleeding occur.17 Approximately half of the patients who enter
the toxic phase will die within 7 to 10 days.17 Fortunately, a highly effective, safe, and
affordable vaccine against the yellow fever virus is available and provides lifelong
immunity to yellow fever disease.17
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Figure 5. Distribution of yellow fever in Africa. Figure obtained from the Centers for Disease Control and Prevention.
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Figure 6. Distribution of yellow fever in South America. Figure obtained from the
Centers for Disease Control and Prevention.
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1.1.4 Chikungunya
Chikungunya virus (CHIKV) is an alphavirus transmitted by infected Ae. aegypti
mosquitoes; the disease shares many of the symptoms associated with dengue (fever,
joint pain, headache, nausea, fatigue, and rash).18 There is no vaccine or antiviral
treatment available for chikungunya so treatment focuses only on symptoms of the
disease.18 Joint pain associated with chikungunya can be extremely debilitating and can
persist for months or even years. The name “chikungunya” originates from Makonde (or
Kimakonde) root word kungunyala, meaning “to become contorted,” and describes the
stooped posture of those suffering from the associated extreme joint pain. Chikungunya
has been identified in more than 60 countries within Asia, Africa, Europe, and North and
South America (Figure 7).18 Many individuals living in areas with endemic chikungunya
depend on manual labor to support themselves and their families. While patients usually
recover from chikungunya infection, the temporary inability to work can have detrimental
effects on these impoverished populations. Cases of imported chikungunya have been
reported in Canada, Mexico, and the United States.18 Twelve locally acquired cases of
chikungunya were reported in Florida in 2014 and one was reported in Texas in 2015.19
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Figure 7. Global distribution of Chikungunya. Countries and territories in which locally acquired chikungunya cases have
been reported as of April 22, 2016. Figure obtained from the Centers for Disease Control and Prevention.
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1.2 Vector Control Strategies
Ae. aegypti mosquito populations are spreading worldwide and are predicted to
continue to spread as temperatures rise due to climate change, creating more
environments ideal for mosquitoes and increasing human exposure to the mosquito.20,21
With no effective treatment for Dengue, Zika, or Chikungunya infection, no vaccines
available to combat these viruses, and a relentless increase in vector-borne disease cases
reported globally, there is a vital need to control the disease through the only available
method: vector control.3,15,22,23
1.2.1 Current Methods
Current vector control strategies include environmental management, and biological
and chemical methods.3 Environmental management techniques aim to alter controllable
factors that contribute to the presence of available larval habitats for Ae. aegypti
populations.3 As such, mosquito population prevalence is often correlated to poor water
supply, sanitation, and waste disposal, which these environmental management
techniques are designed to address.3 When properly applied, these methods can
significantly reduce mosquito populations. However, these methods have obvious
limitations: they are dependent on human behavior and awareness, requiring that all
individuals of a population be knowledgeable of these practices, and can be ineffective in
areas containing natural water reservoirs (tree or rock holes). Additionally, environmental
management can be difficult to successfully implement in underdeveloped areas or in
areas with limited resources.
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Biological control of vector populations utilizes known ecological species
interactions to decrease target mosquito populations by introducing predatory, competing,
parasitic, or pathogenic organisms into the ecosystem.3 However, these methods are often
impractical to employ in many urban settings and can have adverse effects on
ecosystems.3 Recent studies suggest that release of genetically modified male Ae. aegypti
mosquitoes carrying a homozygous dominant lethal gene can reduce mosquito
populations; the transgenic males can compete with native male mosquitoes and
procreate with female mosquitoes to produce offspring with an expressed lethal gene that
causes death in embryonic or larval stages.24 While initial studies appear promising,
research has been limited and public opinion of the practice can be extremely
controversial; there is also uncertainty in the future of research and implementation of
this method due to issues associated with regulation.25,26 Until further research is
conducted, it is unclear whether the use of genetically modified mosquitoes would be a
viable option to control mosquito populations. Another biological method gaining in
notoriety involves releasing Ae. aegypti mosquitoes that have been experimentally
infected with specific strains of Wolbachia (a bacterial symbiont) to establish long-term
infection in the mosquito population.27 Infection by Wolbachia has been shown to reduce
Ae. aegypti life span, egg viability, and blood feeding success in addition to increasing
mosquito resistance to DENV infection.27 While this method of vector control may have
potential to positively impact human health, the effectiveness varies for various DENV
serotypes and it would likely be insufficient in high-transmission areas.27 Biological
methods are typically expensive and impractical to implement at large scales and benefits
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outweighing potential damage to ecosystems are often short-sighted since mosquito
populations usually recover.
Chemical vector control methods depend on the use of insecticides, which can either
target mosquito larvae (larvicides) or adult mosquitoes (adulticides). Insecticides act as
neurotoxicants, disturbing calcium homeostasis and other molecular mechanisms, which
are not species-specific.28 There are numerous types of insecticides, classified by
chemical structure and mode of action: pyrethroids cause voltage-gated sodium channels
to remain activated; organophosphates irreversibly inhibit the enzyme
acetylcholinesterase; organochlorine insecticides can target voltage-gated sodium
channels or receptors that respond to either glycine or to the neurotransmitter
gamma-aminobutyric acid (GABA); neonicotinoids target nicotinic acetylcholine
receptors.28 While insecticides currently act as the most potent tool available for
controlling mosquito populations, insecticides should only be used in emergencies or in
situations in which no other methods would be beneficial. Since insecticides are not
species-specific, they can be toxic to humans and other ecologically significant
populations. Pesticide use has been known to have devastating off-target effects on other
animals, including honeybees and other pollinators.29,30 Another concern associated with
reliance on insecticides is the growing trend of mosquitoes exhibiting insecticide
resistance. The increasing frequency of Ae. aegypti insecticide resistance necessitates
research towards the development of novel vector control methods that do not drive
mosquito evolution towards resistance.2,3,31-34 New methods to address vector control are
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vitally needed due to increased pathogen drug resistance, lack of effective disease
treatment or vaccine options, and increased insecticide resistance.2
1.2.2 Ae. aegypti Midgut Serine Proteases
A human blood meal is required by female Ae. aegypti mosquitoes to supply the
nutrients necessary for metabolism and oogenesis.35 Digestion of blood proteins occurs in
the midgut via proteases: a dramatic increase in protease activity occurs in the Ae. aegypti
midgut upon blood intake.36,37 Proteases are proteolytic enzymes that release an amino
acid or peptide from a larger peptide or protein; endopeptidases act on internal peptide
bonds while exopeptidases act on the peptide bonds of amino acids at the N- or
C-terminus.38 Within the Ae. aegypti midgut, serine proteases, in addition to
exopeptidases, are responsible for the rapid digestion of blood and, thus, contribute to
mosquito fecundity.35 Inhibiting the activity of proteases necessary for blood meal
digestion may be an effective way to manage mosquito populations and consequently,
transmission of associated viral pathogens. Previous research confirms that reducing the
percentage of blood in the female mosquito blood meal significantly decreases the
amount of viable eggs produced.22 By effectively inhibiting the digestion of blood meal
proteins with synthetic peptide analog inhibitors, the mosquito would be unable to render
nutrients from the blood necessary for egg development, reducing the population of
future mosquito generations.
Proteases have catalytic sites consisting of either amino acid or water nucleophiles.39
Serine proteases are named for the nucleophilic serine residue in the enzyme active site.40
The nucleophilicity of the serine hydroxyl group is dependent on aspartate and histidine
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residues, which, along with serine, make up the catalytic triad or charge relay system
(Ser-195, His-57, and Asp-102 according to bovine chymotrypsin numbering convention)
(Figure 8).40 Compression of the hydrogen bond between the histidine and aspartate
residue results in a low-barrier hydrogen bond, increasing the pKa of the histidine residue
and allowing the histidine residue to act as an enhanced general base and hydrogen ion
acceptor; the aspartate residue orientates the imidazolium ring of the histidine residue,
making histidine a better proton acceptor and bringing serine and histidine into closer
proximity.41 While the pKa value of a serine hydroxyl group is generally too high for
deprotonation to be favorable in physiological conditions, this hydrogen bonding network
results in polarization of the hydroxyl group of the serine residue side chain, which can
then be deprotonated to prevent formation of an unfavorable positive charge on the serine
hydroxyl group and makes the serine residue an extremely powerful nucleophile.38,41,42

Figure 8. Catalytic Triad. The charged aspartic acid side chain orientates the
imidiazolium ring of the histidine residue, which acts as a general base and can
deprotonate the hydroxyl group on the serine residue, generating the alkoxide ion that can
act as an extremely powerful nucleophile.
The mechanism of peptide hydrolysis (Figure 9) proceeds in the following steps,
beginning with (1) substrate binding, followed by (2) a nucleophilic attack on the
substrate carbonyl carbon of the peptide bond by the activated hydroxyl group of serine
195. This alters the geometry of atoms around the carbon, resulting in an unstable
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tetrahedral intermediate with a negatively charged oxygen atom stabilized by the
oxyanion hole (hydrogen bonding by backbone NH groups). Proton transfer from the
histidine residue to the newly formed amino group (at the substrate cleavage site) leads to
(3) collapse of the tetrahedral intermediate, producing the acyl-enzyme. The N-terminal
region of the cleaved substrate can then (4) leave the enzyme active site and is then
replaced by a water molecule. The water molecule attacks the carbonyl group and the
histidine residue removes a proton, (5) forming a second tetrahedral intermediate.
Collapse of the second tetrahedral intermediate leads to (6) formation and release of the
carboxylic acid product. Afterwards, the enzyme catalyst is regenerated and ready for
subsequent catalysis.42 This mechanism is common among all serine proteases, which
include trypsin, chymotrypsin, elastase, and serine collagenase. Studies focusing on the
Ae. aegypti mosquito have revealed that the major serine protease involved in the blood
meal digestion process are trypsin-like enzymes.22,23
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Figure 9. Serine protease enzyme mechanism.
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Blood meal digestion in Ae. aegypti mosquitoes occurs in a biphasic manner; midgut
trypsin-like activity increases during the early phase of digestion, 0 to 6 h post blood
meal (PBM), and the late phase of digestion shows a more dramatic increase 12-18 h
PBM.22,43 Three serine proteases showing the highest expression levels in female Ae.
aegypti were initially characterized: early trypsin (AaET), late trypsin (AaLT), and 5G1
(AaSPVI).43,44 Completion of the Ae. aegypti genome and subsequent bioinformatics
analyses identified another abundant protease, AaSPVII, in addition to other midgut
proteases.22,35,45 Of the hundreds of serine protease-like genes in the Ae. aegypti genome,
66 were identified as potential trypsins and just nine of these were found to be expressed
in the midgut.35,45 Trypsin belongs to the serine protease family [subclan PA(S)] and is
vital in Ae. aegypti blood meal digestion.38,46 Trypsins cleave peptide substrates on the
C-terminal side of lysine or arginine. Mammalian trypsins have the ability to activate
trypsinogen, the zymogen form of trypsin; it has been proposed that mosquito trypsin-like
serine proteases may also display autocatalytic behavior (autoactivation) but has not yet
been shown definitively.44
Knockdown studies of the four most abundant Ae. aegypti proteases have shown that
only three have an effect on mosquito fecundity: AaLT, AaSPVI, and AaSPVII.22 While
mRNA knockdown of each individual protease resulted in a decrease in the amount of
eggs laid by the mosquito, knockdown of all three of these proteases at once did not have
an overall additive decrease as expected.22 This suggests that other Ae. aegypti midgut
enzymes may compensate for this loss of activity.22
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In order to determine which proteases may play a significant role in this process,
expression profiles were determined for the other nine Ae. aegypti midgut serine
proteases.35 Expression profiles for Ae. aegypti serine proteases II–V (AaSP group I)
show that these genes are expressed at constant levels before and after blood meal
acquisition.35 Therefore, is possible that AaSP group I proteases may be responsible for
protease activity observed following knockdown of abundant proteases.35 High sequence
similarity between AaSP group I genes prevented researchers from determining
individual gene transcript levels; instead, the cumulative level of AaSP group I genes
were quantified from whole body Ae. aegypti genomic DNA libraries.35 Initial sequence
analyses show that these enzymes are trypsin-like serine proteases each containing six
cysteine residues corresponding to three highly conserved disulfide bonds; serine
proteases II and IV (AaSPII and AaSPIV) sequences contain two additional cysteine
residues for a total of four disulfide bonds in the native conformation.35 Sequence
alignments show the AaSP group I genes belong to the same clade, with highest sequence
similarity between AaSPII and AaSPIV (96% sequence identity).35 Therefore, the degree
to which individual proteases belonging to the AaSP group I are expressed in the
mosquito midgut remains unknown.35
Results from mRNA knockdown experiments suggest that inhibiting blood meal
metabolism in Ae. aegypti may additionally require inhibition of compensatory proteases.
Such development of specific inhibitors requires prior biochemical studies aimed at
enzyme characterization, which have not yet been performed for AaSP group I proteases
and other proteases with lower expression levels. Specifically, AaSPII and AaSPIV are of
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particular interest in this study. These genes will be cloned and studied in vitro to gain
insight into their function and determine their potential roles in the Ae. aegypti blood
meal process.
1.3 Recombinant Protein Expression in Escherichia coli
Natural protein quantities are often insufficient for biochemical study; instead,
recombinant technologies are frequently used in biochemical research to obtain pure,
soluble, and functional proteins of interest.47 Large quantities of recombinant protein for
biochemical studies can be produced by utilizing simple prokaryotic organisms such as
Escherichia coli and bacterial specific plasmid expression vectors.48 Expression using E.
coli as the host is often employed; however, using prokaryotic expression systems for
eukaryotic proteins may not always be successful and can cause expression of insoluble
protein.47 The E. coli cytoplasm is maintained in a reduced state primarily through
thioredoxin and glutaredoxin systems, which makes disulfide bond formation in proteins
unfavorable.49-51 The thioredoxin system comprises of thioredoxin reductase and
thioredoxin and the glutaredoxin system consists of glutathione reductase, glutathione,
and three glutaredoxins.51 Both systems use NADPH to reduce disulfide bonds in
enzymes expressed in the E. coli cytoplasm.51 Therefore, using E. coli to express proteins
requiring multiple disulfide bonds, such as AaSPII and AaSPIV, to maintain structure and
function may result in the expression of misfolded proteins (or inclusion bodies) when
necessary disulfide bonds are reduced.47 Several strategies have been developed in an
effort to overcome such obstacles in expressing eukaryotic recombinant protein and
include both preventative and consequent techniques.47 Specifically, three subsets of
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methods are commonly used to obtain soluble, active protein from E. coli: those that
attempt to modify the in vivo parameters without modifying the target protein; those that
involve modifying the target protein; and those that employ in vitro refolding methods.47
Numerous strategies in which target modification is avoided exist and can include:
cultivating bacteria at reduced temperatures, adjusting growth media components, using
mutant E. coli strains engineered to promote solubility, or addition of appropriate binding
cofactors, binding partners, or molecular chaperones.47 When these methods are
unsuccessful, it may be necessary to engineer the target protein by attaching a more
soluble species as a fusion protein.47 In cases of unavoidable protein aggregation and
inclusion body formation, solubilization and refolding methods can be used; however,
this often results in poor recovery or inactive enzyme.52
1.4 Protein Purification Techniques
Upon successful soluble protein expression, it is necessary to purify the target
enzyme. Often, a series of purification steps are executed to ensure homogeneity of the
final product.53 Ion exchange chromatography is one purification method that can be
employed. Ion exchange chromatography separates proteins based on charge type and
relative strength; it is dependent on the interaction between charged amino acid residues
in the sample and ions in the column stationary phase.54 At physiological pH, the amino
acids lysine, arginine, and histidine are positively charged while aspartate and glutamate
are negatively charged. The overall charge of the target protein is dependent on pH and
the amino acid sequence, which determines the protein’s isoelectric point (pI).
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Another common method of protein purification is immobilized metal affinity
chromatography (IMAC). Specific amino acids located on the protein surface can bind to
certain metal ions; this interaction is exploited in IMAC for protein purification. Protein
binding in IMAC is dependent on the histidine residues accessible on the protein’s
surface, as histidine shows the strongest interaction with immobilized metal matrices due
to the electron donating groups on the imidazole ring of histidine that readily coordinate
with the metal.55-57 Histidine-tagged fusion proteins can be purified in this manner with
the use of Ni(II) or other divalent ions. Histidine-tagged proteins can be applied to IMAC
column matrices and impurities can be removed with washing; the target protein can then
be eluted simply by adjusting the pH or adding free imidazole to the column.57 There are
several advantages in using IMAC for purification; for example, there is usually low
contamination from bacterial proteins due to the high selectivity of histidine-tagged
protein to the metal.58
Size-exclusion chromatography is another technique that can be used to purify
proteins and is often employed as the final step in the purification process. In
size-exclusion chromatography, sample components separate based on molecular size and
shape; separation performed by size-exclusion chromatography is determined by the pore
size of the column matrix.59 Larger proteins that cannot move through the pores instead
travel around the matrix and elute prior to smaller proteins; because small proteins can fit
through all of the pores in the matrix, they take a longer path and thus elute last.53
Because purification is not dependent on binding of the target protein, this method is
generally less susceptible to protein loss.53
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1.5 Protease Characterization Techniques
Upon successful purification of the target protein, biochemical methods of enzyme
characterization can be performed. Trypsin-like activity can be efficiently measured
using Nα-benzoyl-D,L-arginine-p-nitroanilide hydrochloride (BApNA), a synthetic
colorimetric substrate for trypsin.43,60,61 Trypsin-like proteases will cleave BApNA to
generate p-nitroaniline (pNA), which is yellow in color and can be detected at 410 nm;
the color intensity of pNA is directly proportional to concentration, allowing for an
accurate measurement of protease activity.60 Total enzyme activity can be determined by
observing the production of pNA from BApNA via a UV-visible spectrophotometer and
using the extinction coefficient, ε410nm = 9960 M-1cm-1.60
Characterization typically also involves the determination of the three-dimensional
enzyme structure in order to understand the catalytic mechanism, identify the enzyme
active site, and determine the substrate binding mechanism for the potential development
of inhibitors. The primary methods to determine protein structure at atomic resolution are
protein crystallography and nuclear magnetic resonance (NMR) spectroscopy. Protein
crystallography involves collecting data of an X-ray beam being diffracted by a protein
crystal and can provide an electron density model of the crystal.62 Often, the most
difficult aspect of protein crystallography is forming the crystal; proteins are large,
irregularly shaped, and dynamic macromolecules that do not easily form an ordered
crystal lattice.63 The greatest limitation of protein crystallography is that it requires
crystallization of the protein, which renders the protein target immobile and may not be
representative of dynamic protein structures in solution.
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NMR spectroscopy can be applied to proteins in solution and uses radiowaves that
interact with the protein in a strong magnetic field and can be used for proton
localization, which can be difficult to determine via crystallography.62,64 Because it does
not require protein crystallization, NMR spectroscopy can be used to study reaction
kinetics and dynamics.65 However, proteins large in size can be extremely difficult to
study using protein NMR as spectra become quite complex. Often, complementary
techniques can be used for structure determination to resolve various aspects of protein
structure.
1.6 Specific Research Aims
Research herein aims to understand the role of Ae. aegypti trypsin-like midgut serine
proteases II and IV (AaSPII and AaSPIV). Specifically, in vitro biochemical studies of
AaSPII and AaSPIV will involve successful cloning and bacterial expression of soluble,
recombinant enzyme and protein purification in preparation for biochemical analyses.
Studying AaSPII and AaSPIV, as well as other midgut Ae. aegypti proteases, will aid in
understanding the overall role of proteases involved in blood meal digestion and may
eventually allow for the development of potential enzyme inhibitors to inhibit egg
production, minimize mosquito populations, and hopefully lead to a decrease in viral
pathogen transmission.
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CHAPTER 2: METHODS
2.1 Preparation of Protease Plasmid Constructs
2.1.1 General Cloning Strategy
Gene-specific polymerase chain reaction (PCR) primers for serine proteases AaSPII
and AaSPIV were designed manually using a modified cloning PCR strategy to generate
a gene product containing the appropriate base pair region encoding the AaSPII or
AaSPIV gene from cDNA isolated from blood-fed mosquitoes (Table 1 and Table 2).66
All primers were checked using NetPrimer
(http://www.premierbiosoft.com/netprimer/netprlaunch/netprlaunch.html) for appropriate
parameters including: length, melting temperature (Tm), potential hairpin and
primer-dimer formation, and G-C content.
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Table 1. Primers used for PCR amplification and cloning of recombinant forms of the
full length zymogen (with leader), mature form (no leader), MBP-fusion, EK-pseudo
propeptide, and mutant (Ser to Ala and Lys to Ala) AaSPII.

Protease

AaSPII

AaSPII

EK-AaSPII

Leader

With
Leader

No
Leader

No
Leader

Target
Vector
for
Cloning

Primer

5'-AAAAAGCTAGCATGTGG
TTTTCTGTGAAAATATCG -3'
5'- AAAAACTCGAGTTATT
ACACAACCCAAACCGCTC -3'
5'- AAAAAGCTAGCATGTC
GGTGGACAACGACGTG -3'
5'- AAAAACTCGAGTTATT
ACACAACCCAAACCGCTC -3'
5’- AAAAAGCTAGCAACAACA
ACCTCGGCGATGACGATGACA
AGATCATCGGTGGTTTTCCCG -3’
5’- AAAAACTCGAGTTATTAC
ACAACCCAAACCGCTC -3’
5'- AAAAACCATGGGCAGC
AGCCATCATCATC -3'
5'- AAAAAGAATTCTTATTACA
CAACCCAAACCGCTCT -3'
5’- CTCTTGCCAGGGTGATGC
CGGGGGTCCTTTGG -3’
5’- CCAAAGGACCCCCGGC
ATCACCCTGGCAAGAG -3’
5’- CGGTGGACAACGACGTG
GCGATCATCGGTGGTTTTC -3’
5’- GAAAACCACCGATGATC
GCCACGTCGTTGTCCACCG -3’
5'- AAAAACCATGGGCTCGG
TGGACAACGACGTG -3'
5'- AAAAACTCGAGCACAAC
CCAAACCGCTCTG -3'

Fwd
pET28a
Rev
Fwd
pET28a
Rev
Fwd
pET28a
Rev

MBPAaSPII

No
Leader

pMALc5E

AaSPII Ser
to Ala
Mutant

No
Leader

pET28a

AaSPII Lys
to Ala
Mutant

No
Leader

pET28a

AaSPII

No
Leader

Primer Sequence

Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd

pET29b
Rev
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Table 2. Primers used for PCR amplification and cloning of recombinant forms of the
full length zymogen (with leader), mature form (no leader), MBP-fusion, EK-pseudo
propeptide, and mutant (Ser to Ala and Lys to Ala) AaSPIV.

Protease

AaSPIV

AaSPIV

EKAaSPIV

Leader

With
Leader

No
Leader

With
Leader

Target
Vector
for
Cloning

Primer

5’- AAAAAGCTAGCATGTGGTTTT
CTGTGAAAATATCG -3’
5’- AAAAACTCGAGTTACACAACC
CAAACCGCT -3’
5'- AAAAAGCTAGCATGTCGGTGG
ACAACGACATGA -3'
5’- AAAAACTCGAGTTACACAACC
CAAACCGCT -3’
5’-AAAAAGCTAGCAACAACAACC
TCGGCGATGACGATGACAAGATCA
TCGGCGGTTTTCC-3’
5’- AAAAACTCGAGTTACACAACC
CAAACCGCT -3’
5'- AAAAACCATGGGCAGCAGCCA
TCATCATC -3'
5'- AAAAAGAATTCTTACACAACC
CAAACCGCT -3'
5’- CTCTTGCCAGGGTGATGCCGG
GGGTCCTTTGG -3’
5’- CCAAAGGACCCCCGGCATCAC
CCTGGCAAGAG -3’
5’- CGGTGGACAACGACATGGCGA
TCATCGGCGGTTTTC -3’
5’- GAAAACCGCCGATGATCGCCA
TGTCGTTGTCCACCG -3’
5'- AAAAACCATGGGCTCGGTGGA
CAACGACATGAA -3'
5'- AAAAACTCGAGCACAACCCAA
ACCGCTCTG -3'

Fwd
pET28a
Rev
Fwd
pET28a
Rev
Fwd
pET28a
Rev

MBPAaSPIV

With
Leader

pMALc5E

AaSPIV
Ser to Ala
Mutant

With
Leader

pET28a

AaSPIV
Lys to Ala
Mutant

With
Leader

pET28a

AaSPIV

No
Leader

Primer Sequence

Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd

pET29b
Rev
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PCR reactions were performed to obtain the target gene region. Each reaction
contained 1X GoTaq Green Master Mix (Promega # M7128), 0.5 μM Forward Primer,
0.5 μM Reverse Primer, 25 ng DNA template, and nuclease-free water to 15 μL. All PCR
reactions were performed in an Eppendorf 5331 MasterCycler Gradient Thermal Cycler
with cycling parameters as listed (Table 3).
Table 3. Cycling Parameters for PCR amplification of recombinant forms of the full
length zymogen (with leader), mature form (no leader), MBP-fusion, EK-pseudo
propeptide, and mutant (Ser to Ala and Lys to Ala) AaSPII and AaSPIV.
Steps
Cycles Temperature Time
Initial Denaturation
1
5 min
95 °C
Denaturation
20 s
95 °C
Annealing
25
20 s
58 °C
Extension
20 s
72 °C
Final Extension
1
5 min
72 °C
Hold
HOLD
1
20 °C
PCR reaction success was evaluated by performing electrophoresis on reaction
samples in a 1% agarose gel containing a 1:10000 dilution of GelRed Nucleic Acid Gel
Stain (Biotium # 41002). The gel was then visualized by UV transillumination. Success
of the PCR reactions was determined by the presence of a band near the correct
molecular weight (predicted size of the PCR product) using a standard DNA ladder
(Thermo Scientific GeneRuler 1 kb DNA Ladder, # SM0311). Successful PCR products
were carefully excised and extracted from the gel using the Thermo Scientific GeneJET
Gel Extraction Kit (# K0692) and eluting with 20 μL ultrapure water. The PCR products
extracted from the gel were digested with 1 μL of each restriction enzyme (Thermo
Scientific FastDigest restriction enzymes, details listed in following sections) and 1X
FastDigest Buffer (Thermo Scientific # B64) prior to incubation at 37 °C for 1.5 h.
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Vector digestion was performed in preparation for insertion of PCR products by
combining 1000 ng vector, 1 μL of each restriction enzyme, 1X FastDigest Buffer
(Thermo Scientific # B64), and nuclease-free water to 20 μL. The mixture was incubated
at 37 °C for 1.5 h. Digestion mixture was then incubated at 90 °C for 10 min and then on
ice for 1 min. Dephosphorylation of the digested vector was performed by adding 1 μL
FastAP Thermosensitive Alkaline Phosphatase (Thermo Scientific # EF0654) and
incubating for 1.5 h at 37 °C. Digested and dephosphorylated vector solutions were also
run on a 1% agarose gel containing a 1:10000 dilution of GelRed Nucleic Acid Gel Stain
(Biotium # 41002). Vector bands were excised from the gel and combined with digested
PCR products and co-purified using the Thermo Scientific GeneJET Gel Extraction Kit
(# K0692) and eluted with 20 μL nuclease-free water.
Both vector and PCR product were digested with the same restriction enzymes in
order to introduce the complimentary “sticky ends” to aid in successful ligation forming
the plasmid of interest. PCR products and vector ligation was performed by adding 1 μL
T4 DNA Ligase (NEB # M0202S) and 1X T4 DNA Ligase Reaction Buffer (NEB
# B0202S) and incubating at room temperature for 20 min.
NEB 10-beta Competent E. coli cells (# C3019H) were briefly thawed on ice in
preparation for transformation of the ligated plasmid. Immediately after cells were
thawed, 10 μL from the ligation reaction was added to the cells. The mixture was mixed
by flicking the tube 4–5 times and incubated for 30 min on ice. Cells were heat shocked
at 42 °C for 30 s and incubated on ice for 5 min. Cells were combined with 950 μL of
SOC Outgrowth Media (NEB #B9020S) and incubated for 1 h in a 37 °C shaker
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(250 RPM). Centrifugation at 13000 RPM for 1 min was then performed to pellet the
cells and remove 900 μL of growth media. Cells were resuspended in remaining media
and plated on agar containing an appropriate antibiotic [30 mg/mL kanamycin (the
pET28a plasmid construct) or 100 μg/mL ampicillin or 50 μg/mL carbenicillin (either
antibiotic is appropriate for selection of the pMAL-c5E plasmid construct)] to select for
cells containing desired plasmid. Transformation plates were incubated overnight at the
optimal growth temperature. Colonies were then restreaked onto fresh transformation
plates and incubated overnight at the optimal growth temperature. The general cloning
procedure is summarized in Figure 10. Colony PCR was performed for new “stock”
bacterial plates from original transformation colonies to check for successful molecular
cloning. For each “stock”, one PCR reaction was prepared by combining 1X GoTaq
Green Master Mix (Promega # M7128), 0.5 μM Forward Primer, 0.5 μM Reverse Primer,
and nuclease-free water to 15 μL with one colony from the restreaked plate. All PCR
reactions were performed in an Eppendorf 5331 MasterCycler Gradient Thermal Cycler
with cycling parameters as listed in Table 3 and reaction success was assessed via 1%
agarose gel electrophoresis.
For each sample with successful Colony PCR products, one colony was added to
overnight cultures containing 25 mL Luria-Bertani (LB) broth with appropriate antibiotic
for selection. Overnight cultures were incubated overnight (16–18 h) at the optimal
growth temperature with shaking (250 RPM). Plasmids were isolated from cells grown
overnight using the Thermo Scientific GeneJET Plasmid Miniprep Kit (# K0502) and
eluting with 30 μL nuclease-free water. Plasmid concentrations were determined using a
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Thermo Scientific NanoDrop 1000 Spectrophotometer. Plasmid construct DNA
sequences were verified through sequencing.

Figure 10. General molecular cloning procedure. Target genes are PCR-amplified from
Ae. aegypti cDNA and digested with restriction enzymes. The expression vector is
digested with the same restriction enzymes to facilitate ligation of the target gene into the
expression vector. The vector plasmids are then transformed into E. coli.
2.1.2 pET28a Plasmid Constructs
Primers were designed to include the NheI and XhoI restriction sites to enable cloning
of the gene into the pET28a expression vector (Novagen # 69864-3) in addition to a
5’-extension to the restriction site (consisting of 5 adenine bases) to increase cleavage
efficiency of the restriction enzymes.66 Two sets of primers were designed for each target
protein. The gene fragment obtained was ligated into the bacterial expression vector
pET28a downstream of the T7 promoter, lac operator, and N-terminal sequence encoding
six histidine residues (His6-tag) for AaSPII and AaSPIV. Restriction enzymes used in
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cloning process were Fisher Scientific FastDigest NheI (# FD0973) and XhoI
(# FD0694).
The pET28a vector utilizes the inducible T7 expression system in order to express the
cloned gene sequences in E. coli cells (Figure 11). The T7 RNA polymerase coding
sequence is present in E. coli cells and is controlled by the lac promoter and induced by
lactose; the pET28a plasmid is under the control of a promoter recognized by T7 RNA
polymerase.67 Production of T7 RNA polymerase can be artificially induced by
isopropyl-β-D-thiogalactoside (IPTG, a non-hydrolyzable analog of allolactose) and
DNA transcription controlled by the T7 promoter.

Figure 11. Regulation of protein expression with vectors utilizing the T7 expression
system. Binding of IPTG to the lac repressor induces a conformational change preventing
the lac repressor from binding to the lac promoter. This allows E. coli RNA polymerase
to bind and begin transcribing the T7 RNA polymerase. Once T7 RNA is expressed, it
can bind to the T7 promoter and begin transcribing the gene of interest. Figure adapted by
author from Novagen pET System Manual.
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2.1.3 Enterokinase (EK)-Pseudo Propeptide Plasmid Constructs
Since it is unknown whether AaSPII and AaSPIV proteases are autocatalytic or have
trypsin-like activity, an entrerokinase (EK) cleavage site (DDDDK) was incorporated
into a pseudo propeptide region introduced via PCR to allow for in vitro activation by
commercially available recombinant enterokinase (Figure 12).23 The predicted activation
site was identified by sequence analysis using SignalP 4.1
(http://www.cbs.dtu.dk/services/SignalP/). Although the sequence analysis suggested that
the preferred site for activation is at a lysine residue, that site was chosen for design of
the EK Forward Primer. Primers were designed to include the NheI and XhoI restriction
sites to enable cloning of the gene into the pET28a expression vector (Novagen) in
addition to incorporation of the EK cleavage site and 5’-extension to the restriction site
(5 adenine bases). Restriction enzymes used in cloning process were Fisher Scientific
FastDigest NheI (# FD0973) and XhoI (# FD0694). The gene fragment obtained was
ligated into the bacterial expression vector pET28a downstream of the T7 promoter and
lac operator.
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Figure 12. Amino acid sequence of the zymogen polypeptide for AaSPII and AaSPIV.
The protein leader sequence and propeptide region (top) were predicted via sequence
analyses based on the known sequence of bovine trypsin. Hydrophobic residues of the
leader sequence and propeptide region are shown in green, negatively-charged residues in
red, positively-charged residues in blue, and polar uncharged residues in gray. The amino
acid sequence of the engineered EK-pseudo propeptide forms of the recombinant
proteases (bottom) is shown. The EK-pseudo propeptide contains an enterokinase
cleavage site (pink).
2.1.4 pMAL-c5E Plasmid Constructs
Additionally, maltose binding fusion protein constructs were designed and cloned
into the pMAL-c5E vector (NEB # N8110S), which contains the malE gene of E. coli
that encodes the maltose binding protein (MBP). This E. coli strain lacks the T7 RNA
polymerase and instead uses the naturally produced E. coli RNA polymerase from the
bacterial expression cells; expression can still be induced using IPTG. While the exact
mechanism is unknown, MBP has been shown to act as a highly effective enhancer of
target protein solubility when used as a fusion protein.47 Escherichia coli MBP is a
periplasmic protein involved in sugar chemotaxis and transport across the bacterial
envelope.68 AaSPII (no leader) and full length AaSPIV (with leader) were each cloned
into the pMAL-c5E vector using each pET28a vector plasmid construct as a template for
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PCR so that constructs included the His6-tag encoded portion from pET28a constructs for
later use in purification steps (Figure 13). Primers were designed to contain EcoRI and
NcoI restriction sites. Restriction enzymes used in the cloning process were Fisher
Scientific FastDigest EcoRI (# FD0275) and NcoI (# FD0573). The cloned gene was
inserted downstream the malE gene so that the fusion protein contained MBP
N-terminally fused to the target protein (with the His6-tag coding sequence from the
pET28a plasmid construct).

Figure 13. MBP–His6-tag–Protein fusion expected product. To improve soluble
expression of the target protein of interest, the pMAL-c5E vector was utilized to clone
the target gene downstream of the Maltose Binding Protein. However, the target gene
included the N-terminal His6-tag sequence in order to produce the above fusion.
2.1.5 pET29b Plasmid Constructs
Additional plasmid constructs using the pET29b vector were developed by students at
San Jose State University as part of the Fall 2016 Chem 131B lab course using methods
described here. Primers were designed to include the NcoI and XhoI restriction sites to
enable cloning of the gene into the pET29b expression vector (Novagen) in addition to a
5’-extension to the restriction site (5 adenine bases). Unlike the pET28a vector, inserting
the gene fragment into the pET29b vector incorporates a C-terminal sequence encoding
six histidine residues (His6-tag) for AaSPII and AaSPIV. Therefore, reverse primers
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designed did not encode stop codons to allow for incorporation of a C-terminal His6-tag.
The gene fragment obtained was ligated into the bacterial expression vector pET29b
downstream of the T7 promoter and lac operator. The pET29b vector also utilizes the
inducible T7 expression system in order to produce proteins from cloned sequences in
E. coli cells and production of T7 RNA polymerase can be experimentally induced by
IPTG (Figure 11).
2.1.6 Site-Directed Mutagenesis
Site-directed mutagenesis reactions were used to introduce single base point
mutations into the known DNA plasmid templates using the Thermo Scientific Phusion
Site-Directed Mutagenesis Kit (# F541). Two complimentary oligonucleotide primers
were designed for each reaction to incorporate the desired mutation using guidelines
described for the Stratagene QuikChange Site-Directed Mutagenesis Kit (# 200518).
Two sets of mutagenesis primers were designed for different mutations: (1) primers
for mutating the active site serine residue to an alanine residue and (2) primers for
mutating the predicted cleavage site residue (lysine) to an alanine residue. Both mutants
were designed to prevent potential autoactivation of the recombinant enzymes. Reactions
were prepared by mixing components to a final volume of 50 µL (Table 4). Reactions
were performed in an Eppendorf 5331 MasterCycler Gradient Thermal Cycler with
parameters described (Table 5).
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Table 4. General PCR Reaction for Site-Directed Mutagenesis Reaction – Single Base
Point Mutation
Component
Quantity
*
5X Phusion HF Buffer
10 µL
10 mM dNTPs*
1 µL
10 mM Forward Primer
2.5 µL
10 mM Reverse Primer
2.5 µL
1 ng/µL Plasmid Template DNA
1 µL
*
2 U/µL Phusion Hot Start DNA Polymerase
0.5 µL
Nuclease-Free Water
32.5 µL
Table 5. Thermal Cycler Parameters for Site-Directed Mutagenesis Reaction – Single
Base Point Mutation
Steps
Cycles Temperature Time
Initial Denaturation
1
30 s
98 °C
Denaturation
10 s
98 °C
Annealing
25
30 s
65 °C
Extension
3
min
72 °C
Final Extension
1
5 min
72 °C
Hold
1
HOLD
20 °C
All plasmid constructs developed are summarized in Table 6. Plasmid constructs are
displayed by the assigned annotation, which indicates: the target protein it encodes
(wild-type AaSPII, wild-type AaSPIV, mutated Ser to Ala AaSPII, or mutated Ser to Ala
AaSPIV); the plasmid used to facilitate expression; whether the inserted gene sequence
includes the leader sequence or not; and notable features of each plasmid construct.
Primers for mutating the predicted cleavage site lysine residue were designed but have
not yet been cloned into a vector plasmid; mutants listed in the table are those with
mutations aimed at changing the active site serine residue.

*

Included in Thermo Scientific Phusion Site-Directed Mutagenesis Kit (# F541)
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Table 6. Summary of plasmid constructs developed for expression of recombinant forms of the full length zymogen (with
leader), mature form (no leader), MBP-fusion, EK-pseudo propeptide, and mutant (Ser to Ala and Lys to Ala) AaSPII and
AaSPIV.
Annotation
AaSPII-pET28a
AaSPII-NL-pET28a
EK-AaSPII-pET28a
AaSPII-NL-pMAL
AaSPII-NL-pET29b
AaSPII-NL-Ala-pET28a**
AaSPIV-pET28a
EK-AaSPIV-pET28a
AaSPIV-pMAL
AaSPIV-NL-pET29b
AaSPIV-Ala-pET28a**

Target Protein

Vector
pET28a
pET28a
WT AaSPII
pET28a
pMAL-c5E
pET29b
Mutant AaSPII pET28a
pET28a
pET28a
WT AaSPIV
pMAL-c5E
pET29b
Mutant AaSPIV pET28a

**

Leader Sequence
With Leader
No Leader
No Leader
No Leader
No Leader
No Leader
With Leader
With Leader
With Leader
No Leader
With Leader

Notable Feature
N-terminal His6-tag
N-terminal His6-tag
N-terminal His6-tag and EK cleavage site
N-terminal MBP and His6-tag
C-terminal His6-tag
N-terminal His6-tag and Mutated Ser to Ala
N-terminal His6-tag
N-terminal His6-tag and EK cleavage site
N-terminal MBP and His6-tag
C-terminal His6-tag
N-terminal His6-tag and Mutated Ser to Ala

Plasmids were constructed for mutation of the active site serine residue to an alanine residue and cloning was successful but
experiments for the successful recombinant protein expression of the mutant proteases in E. coli have not yet been performed
and are therefore not discussed in the Results section (Chapter 4).
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2.2 Recombinant Protein Expression
SHuffle T7 competent E. coli cells were chosen for bacterial expression of AaSPII
and AaSPIV because they were engineered to express cytoplasmic proteins containing
disulfide bonds and are compatible with expression using the T7 promoter system.69
Plasmid constructs were transformed into SHuffle T7 competent E. coli cells (NEB
# C3029H) and grown overnight on LB agar with 30 mg/mL kanamycin (the pET28a
plasmid construct) or 100 μg/mL ampicillin or 50 μg/mL carbenicillin (either antibiotic is
appropriate for selection of the pMAL-c5E plasmid construct) at 30 ºC. One colony from
the overnight plate growth was added to 50 mL LB with appropriate antibiotic and grown
overnight (16−18 h) at 30 ºC with shaking (250 RPM). The optical density at 600 nm
(OD600) of a ten-fold diluted sample was used to measure culture growth in a Hewlett
Packard 8452A Diode Array Spectrophotometer and a 1-cm path-length cuvette.
2.2.1 Induction by IPTG
Six 1-L Erlenmeyer flasks each containing either 500 mL LB or 500 mL Terrific
Broth (TB) media with proper antibiotic (based on plasmid antibiotic resistance) and an
appropriate volume of overnight culture to start at an OD600 of 0.05 was incubated at
30 ºC with shaking (250 RPM) until reaching OD600 between 0.8 and 1.0. At this time,
recombinant expression of the target protein (AaSPII or AaSPIV) was induced with 0.1
M IPTG, the growth temperature dropped to 10 ºC or 15 ºC (250 RPM), and grown for up
to 96 hours. 1 mL samples were collected at various time-points throughout the growth
(determined by hours post induction), centrifuged at 13000 RPM for 5 min, and pellets
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stored at –20 ºC. At the growth experiment endpoint, cell paste was collected by
centrifugation at 6000 RPM and flash frozen in liquid nitrogen before storage at –80 ºC.
2.2.2 Auto-Induction
Methods used for bacterial growth and recombinant protein expression by
auto-induction was designed with parameters according to the auto-induction process
outlined by Studier.70 Auto-induction processes use rich media in order to accomplish
high cell densities, auto-induction (without the use of IPTG), and maximum target protein
yields.70,71 Studier’s ZYM-5052 auto-induction media, which was also used for this
study, contains: N-Z-amine (an enzymatic digest of casein), glucose and glycerol to
support growth to high densities, carbon sources, buffer to maintain pH, critical nitrogen
and magnesium sources.70 Glucose and lactose are both included in the media: glucose
prevents induction by lactose in early stages of growth and, once glucose is depleted,
lactose automatically induces expression of the T7 RNA polymerase.70 Auto-induction
only works with vectors and bacterial strains containing the T7 expression system, such
as pET28a, as they require the lacUV5 promoter.67,70,71
A 125-mL Erlenmeyer flask containing 50 mL Auto-Induction Media (corresponding
to Studier’s ZYM-5052 medium) with 0.05% w/v lactose, 0.2% w/v glucose, proper
antibiotic, and an appropriate volume of overnight culture to reach final OD600 of 0.05
was incubated at 30 ºC with shaking (250 RPM) until reaching OD600 between 0.5 and
0.8. At this time, the reaction flask was incubated on ice for 5 min and then at 15 ºC with
shaking (250 RPM) and grown for 72 hours. Bacterial cells were obtained at various
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time-points throughout the growth by centrifugation of 1 mL samples from growth media
at 13000 RPM for 5 min and pellets were stored at –20 ºC for further analysis.
2.2.3 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
Time-points collected throughout the growth were assessed for successful
recombinant protein expression by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE). Sodium dodecyl sulfate (SDS) is an anionic detergent that
binds to proteins, denaturing them and resulting in a linear structure with a net negative
charge that is approximately proportional to the protein mass.42 SDS-protein complexes
can then be subjected to electrophoresis within a polyacrylamide gel and will separate
based on size: polypeptide chain mobility is inversely linearly proportional to the
logarithm of their mass so small complexes move more rapidly through the gel.42
Cells pelleted for each time-point sample were resuspended in 20 mM Tris-HCl
buffer pH 8. Buffer amount was determined qualitatively based on the size of the largest
pellet (typically between 250 and 350 µL for growth experiments using induction by
IPTG and between 600 and 700 µL for growth experiments using auto-induction).
Samples were maintained on ice and sonicated for 10 s at 20% for a total of three times
using an ultrasonic probe (Fisher Scientific Model 120 Sonic Dismembrator with 120
Watt power requirement and 20 kHz operating frequency; QSonica Sonicators converter
# CL18 and probe # 4423). In new 1.5 mL microcentrifuge tubes, 20 µL from each of the
total sonicated samples was combined with 3.4 µL 6x SDS Loading Dye. Remaining
sonicated samples were centrifuged at 13000 RPM for 5 min to pellet in fractions and
obtain soluble sample fractions. Then, 20 µL from each of the soluble sonicated samples
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was combined with 3.4 µL 6x SDS Loading Dye. Total and soluble samples with SDS
Loading Dye added were incubated at 90 °C for 4 min intervals, briefly centrifuging
between incubation periods until no visible bubbles remained. Samples were
subsequently loaded into the wells of a NuPAGE Novex 4-12% bis-Tris polyacrylamide
gel (Thermo Scientific # NP0321BOX, # NP0322BOX, # NP0323BOX) along with 6 µL
of a protein standard ladder (Thermo Scientific PageRuler Prestained Protein Ladder,
# 26616). The gel was subjected to electrophoresis in NuPAGE 1x MES SDS Running
Buffer (Thermo Scientific # NP000202; 50 mM MES, 50 mM Tris Base, 0.1% SDS,
1 mM EDTA, pH 7.3) at 180 V for 55 min. Following electrophoresis, the gel was rinsed
three times with approximately 20 mL ultrapure water (purity above 18 MΩ·cm at 25 °C)
for 5 min. The gel was then stained with 20 mL SimplyBlue SafeStain (Thermo Scientific
# LC6065) for at least 1 h and then destained with 20 mL ultrapure water for at least 1 h.
Gels images were obtained using the Alpha Innotech FluorChem 8900 Transillumination
Imaging System Light Cabinet.
2.2.4 His-Stain
To aid in identifying expression of His6-tagged proteins, InVision His6-tag In-gel
Stain (Novex Life Technologies # LC6030) was also used. The stain contains a dye that
is conjugated to a Ni2+-nitrilotriacetic acid complex, which binds specifically to the
six-histidine residues incorporated into the protein of interest. The fluorescent dye can be
detected using a UV transilluminator.
Following SDS-PAGE procedures (as previously described), gels were fixed by
adding 100 mL Fixing Solution (40% v/v ethanol, 10% v/v acetic acid solution),
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microwaving (~1000 W) for 1 min, and incubating with agitation for 10 min at room
temperature. The gels were washed by decanting the Fixing Solution and adding 100 mL
ultrapure water, microwaving for 1 min, and incubating for 5 min with agitation. Then,
the water was decanted and 25 mL InVision His6-tag In-gel Stain (Novex # LC6030) was
added, microwaved for 1 min and incubated with agitation for 40 min at room
temperature. The stain was decanted and gels were then washed by adding 100 mL
20 mM phosphate buffer, pH 7.8, microwaving for 1 min, and incubating at room
temperature for 10 min with agitation (three times). Gels were imaged immediately using
a UV transilluminator, followed by washing with ultrapure water and stained with
SimplyBlue Safe Stain.
2.2.5 Western blotting
The immunoassay technique of Western blotting was used to confirm the successful
expression of the target recombinant proteins. Western blotting involves detection of
proteins on the surface of a polymer sheet by exploiting antibody-antigen interactions.42
A primary antibody specific to the expressed protein is added to the sheet for interaction;
a secondary antibody labeled with enzyme reporters specific to the primary antibody will
complex with the primary antibody.42 Light produced by the enzymatic reaction allows
for detection of the complex; chemiluminescent detection in this manner is extremely
specific and sensitive.
In order to verify the presence of the target recombinant protein containing a His6-tag,
SDS-PAGE was performed as previously described. Following electrophoresis, the gel
was rinsed three times in approximately 20 mL ultrapure water for 5 min and then rinsed
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in 20 mL NuPAGE 1x Transfer Buffer (Thermo Scientific # NP0006) with 10%
methanol for 10–15 min.
Proteins from the gel were transferred to a nitrocellulose membrane (EMD Millipore
# ISEQ00010) via electrophoresis with the membrane on the cathode and the gel on the
anode at 30 V for 1.5 h in NuPAGE 1x Transfer Buffer (Thermo Scientific # NP0006).
The blot (membrane) was briefly rinsed with water and then rinsed with 10 mL 1x TBS
(Tris-buffered saline: 20 mM Tris, 137 mM NaCl, pH 7.5) buffer for 5 min. The blot was
then incubated with Blocking Buffer (3% w/v BSA in 1x TBS with 0.1% Tween 20) at
room temperature for 1 h with shaking. Three 5 min rinses with 10 mL 1x TBST (1x TBS
with 0.1% Tween 20) were performed, followed by an overnight incubation at 4 ºC in
10 mL Primary Antibody Solution prepared by diluting (1:1000) His6-tag Polyclonal
Antibody (Cell Signaling Technology # 2365) in 3% w/v BSA in 1x TBST. Three
subsequent 5 min rinses with 10 mL 1x TBST were performed and the membrane was
then incubated in 10 mL Secondary Antibody Solution prepared by diluting (1:2000)
secondary antibody (GE Healthcare # NA934-1ML, Amersham enhanced
chemiluminescent Anti-Rabbit IgG, horseradish peroxidase linked whole antibody from
donkey) in 3% w/v BSA in 1x TBST for 1 h at room temperature with shaking. Three
final 5 min rinses with 10 mL 1x TBST were performed before imaging the Western blot.
The membrane was incubated with SuperSignal West Pico Chemiluminescent
Substrate (Thermo Scientific # 34077), an enhanced chemiluminescent (ECL) substrate
for low-picogram-level detection of horseradish peroxidase (HRP), for 1 min and
visualized in the Alpha Innotech FluorChem 8900 system equipped with a
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chemiluminescent filter. The image was collected with varying exposure times between 1
and 10 min.
2.3 Protein Purification
2.3.1 Wheat Starch Purification for MBP-Tagged Proteins
In order to purify MBP-tagged target proteins, a purification method using wheat
starch was attempted. The binding of MBP to wheat starch is successful due to the
presence of amylose, which can then be exploited to immobilize the target protein, wash
away contaminants, and elute the MBP-tagged protein with maltose. Maltose binds with
stronger affinity to the MBP tag than the wheat starch, facilitating elution of the
MBP-fusion protein of interest.
Collected cell paste from previous growth was resuspended in 5 mL/g Resuspension
Buffer (20 mM Tris-HCl, 250 mM NaCl, pH 7.2). The cell suspension was maintained on
ice and lysed by sonication at 20% amplitude for a total of 8 min using a pulsing (10 s on,
15 s off) ultrasonic probe (Fisher Scientific Model 120 Sonic Dismembrator with 120
Watt power requirement and 20 kHz operating frequency; QSonica Sonicators converter
# CL18 and probe # 4423). At this point, 20 μL of “total” cell sample was collected. The
lysed cell solution was centrifuged at 16000 RPM for 30 min at 4 ºC and 20 μL of the
soluble fraction (crude lysate) was collected.
Prior to purification, wheat starch is subjected to washing and equilibration. First,
50 g wheat starch was rinsed three times in water: the wheat starch was suspended in
200 mL cold ultrapure water and the solution was centrifuged at 12000 RPM for 10 min

48

at 4 ºC. The supernatant was discarded after each rinse. Three additional rinses with
Resuspension Buffer were then performed.
After equilibration, 100 mL of the diluted crude lysate solution was added to the
equilibrated wheat starch and the mixture was incubated at 4 ºC for 30 min with shaking
(200 RPM). The mixture was centrifuged at 12000 RPM for 6 min at 4 ºC. The
supernatant (Flow Through 1) was decanted and stored at 4 ºC. The wheat starch was
then resuspended in 200 mL Resuspension Buffer and centrifuged at 12000 RPM for
6 min at 4 ºC; collected supernatant was stored at 4 ºC as “Flow Through 2.” Again, the
wheat starch was resuspended in 200 mL Resuspension Buffer and centrifuged at
12000 RPM for 6 min at 4 ºC; collected supernatant was stored at 4 ºC as “Flow
Through 3.” Wheat starch pellet was then resuspended in 50 mL cold Elution Buffer
(20 mM Tris-HCl, 250 mM NaCl, 25 mM maltose, pH 7.2) and incubated at 4 ºC for
15 min with shaking (200 RPM). The solution was centrifuged at 12000 RPM for 6 min
at 4 ºC and the supernatant stored at 4 ºC as “Elution.” The collected elution was again
centrifuged at 16000 RPM for 10 min at 4 ºC to ensure removal of any remaining wheat
starch. Total, soluble, flow through, and elution samples were then analyzed via
SDS-PAGE.
2.3.2 Fast Protein Liquid Chromatography
In preparation for purification of the target protein, cell paste was resuspended in
Buffer A (20 mM Tris-HCl, pH 8); resuspension volume was determined by mass of the
cell paste (5 mL buffer were used per 1 g cell paste). The solution was then sonicated for
10 min total (pulse: 10 s on, 15 s off) at 20% amplitude while on ice to lyse cells.
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Purification of the target protein was performed via Fast Protein Liquid
Chromatography (FPLC; GE Healthcare AKTA Amersham Pharmica Biotech) using a
weak anion exchanger column: HiTrap DEAE Sepharose FF 5 mL (GE Healthcare
# 17-5154-01). Components of the system include: Monitor UPC-900 (GE Healthcare
# 18-1129-74) for monitoring of UV absorption, pH, and conductivity; Pump P-920
(Amersham Biosciences # 18-1125-54) high precision laboratory pump; Fraction
Collector Frac-950 (GE Healthcare # 18608300) for collection in 50 mL polypropylene
conical tubes (Corning Falcon # 352070) and 96-well DeepWell polypropylene 2 mL
microplates (Fisher Scientific # 12-566-121); a 10 mL Superloop (GE Healthcare
# 19-7850-01) for loading sample volumes; and Motor Valve INV 907 for use an
injection valve (GE Healthcare # 18110840). The procedure was designed and monitored
using UNICORN Control Software (GE Healthcare). Methods used for purification
included the following steps: pump wash, column wash, sample loading, and a controlled
linear gradient elution with Buffer B (20 mM Tris-HCl, 1 M NaCl, pH 8). Following
completion of the run, the chromatogram was analyzed based on UV detection in order to
select appropriate fractions to further assess via SDS-PAGE and Western blotting.
Later purification attempts used alternate columns and buffers; each combination
used is summarized in Table 7.
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Table 7. Summary of purification columns and conditions used indicating the type of
resin, whether anion or cation exchange, and buffers used.
Column
HiTrap DEAE Sepharose FF
5 mL (# 17-5154-01)
HiTrap CM Sepharose FF
5 mL (# 17-5155-01)
HiTrap SP Sepharose FF
5 mL (# 17-5157-01)
HiTrap DEAE Sepharose FF
5 mL (# 17-5154-01)

Type
Weak Anion
Weak Cation
Strong Cation
Weak Anion

Buffer A
20 mM Tris-HCl,
pH 8
50 mM sodium
acetate, pH 5.2
50 mM acetic acid,
pH 4.3
20 mM Tris-HCl,
1 mM PMSF, pH 8

Buffer B
Buffer A + 1 M
NaCl
Buffer A + 1 M
NaCl
Buffer A + 1 M
NaCl
20 mM Tris-HCl,
1 M NaCl pH 8

2.4 Qualitative Activity Assay
In order to detect trypsin-like activity in purified fractions, which would suggest that
the recombinant enzymes are active, the synthetic colorimetric substrate for trypsin
BApNA was used. Upon cleavage of BApNA by enzymes with trypsin-like activity, a
yellow product (p-nitroaniline) is generated with color intensity proportional to enzyme
concentration.60 While BApNA can be used as a substrate to obtain kinetic constants once
a protein is successfully purified, for this work, it was used qualitatively to determine
whether or not activity was present in purified fractions.
Each reaction was prepared in a 1.5 mL microcentrifuge tube and contained 20 mM
Tris-HCl, pH 7.2, 10 mM CaCl2, 1 mM BApNA, and ultrapure water for a total volume
of 990 µL. For each reaction, 10 µL from the sample fraction in question was added and
the solution vortexed to mix and incubated at room temperature overnight. Reaction
mixtures were observed to assess the color intensity of solutions that showed a yellow
color following incubation to determine if any samples were positive for trypsin-like
activity.
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CHAPTER 3: RESULTS AND DISCUSSION
3.1 Molecular Cloning
As described in the previous section, PCR amplification (Figure 14) and vector
digestion (Figure 15) steps in the cloning process were qualitatively assessed via agarose
gel electrophoresis.

Figure 14. 1% Agarose gel of AaSPIV PCR products using primers designed for cloning
into the pET28a vector. Lanes 1 and 2 are duplicate PCR reactions at 58 ºC and lane 3 is
the DNA Ladder in base pairs (Thermo Scientific GeneRuler 1 kb DNA ladder). The
expected PCR product is 885 bp (indicated by the arrow).
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Figure 15. 1% Agarose gel of digested and dephosphorylated pET28a vector. Lane 1 is
the DNA Ladder in base pairs (Thermo Scientific GeneRuler 1 kb DNA ladder). Lane 2
contains the digested and dephosphorylated pET28a vector at 5296 bp (indicated by the
arrow).
Following confirmation of successful PCR and vector digestion (Figures 14 and 15), the
digested and dephosphorylated vector was combined with the PCR product, ligated, and
transformed into bacterial cells. Successful cloning was assessed via colony PCR (Figure
16). The AaSPII/pET28a and AaSPIV/pET28a plasmid constructs were then isolated
from the bacterial cells and sequenced to confirm successful molecular cloning.
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Figure 16. 1% Agarose gel of Colony PCR reactions showing positive hits of the
AaSPIV gene. Colony PCR was used to verify successful molecular cloning of the
AaSPIV-pET28a plasmid construct. Lane 9 is the DNA Ladder in base pairs (Thermo
Scientific GeneRuler 1 kb DNA ladder). Lanes 1, 2, 3, 5, 6, and 8 showed a PCR product
in the expected region (885 bp).
Cloning of all constructs of AaSPII and AaSPIV, whether it was for full-length
recombinant proteases, proteases without the leader sequence, incorporation of the
EK-pseudo propeptide or the MBP-fusion tag, was performed as described in the
methods (see Table 6). All constructs were confirmed by sequencing (data not shown).
Sequencing results obtained for the AaSPIV-pET28a plasmid constructs revealed a
change at two specific nucleotides not found in the original AaSPIV gene sequence
annotated in the National Center for Biotechnology Information (NCBI) website.35 The
first nucleotide change led to an amino acid change at position 162 (lysine) to a glutamate
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residue. The second nucleotide that did not match the annotated sequence resulted in an
arginine residue at position 288 (instead of a lysine residue).35 Initially, these two
nucleotide changes were thought to be mutations introduced during the cloning process,
especially since Ae. aegypti cDNA was used as the template. However, these changes
were observed consistently even after multiple cloning attempts were performed,
indicating the possibility that the published Ae. aegypti gene sequence for AaSPIV was
incorrectly annotated, which has been known to occur.72-76 Most cases of misannotation
are associated with overprediction of molecular function.76 Additional problems
associated with genome annotation include: expressed sequence tags (ESTs; short mRNA
sequences derived from cDNA libraries) are susceptible to artifacts, repetitive elements in
cDNA can cause false homology matches, similarities between species do not often take
into account evolutionary divergence or homologs, and alignments can be severely
complicated by alternative splicing.77 To ensure that this was the case, a fresh new batch
of Ae. aegypti cDNA was prepared (by Dr. Jun Isoe, University of Arizona) and the
cloning was repeated by Mr. Bryan Tracy Conner (an undergraduate research student in
the Rascón lab). His experiments resulted in the same amino acid changes observed in the
original AaSPIV-pET28a constructs.
It is also well established that high genetic variability between different Ae. aegypti
strains or between populations in different geographic regions exists, which may also
account for the two observed nucleotide discrepancies.78-80 Potential variation of these
two amino acid residues between Ae. aegypti strains may indicate that the residues are
not highly conserved suggesting that the properties of these specific amino acid residues
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may not be essential for folding or function.42 Often, features of the protein structure
necessary for structure and/or function can depend on general properties associated with
tertiary structure as opposed to conserved protein sequences; these can include exposure
of surface polar or charged residues, which can exchange protons with water.42,81,82
Because the amino acids in question were annotated at lysine residues
(positively-charged) and the amino acids discovered in plasmid constructs were a
glutamate residue (negatively-charged) and an arginine residue (positively-charged) it is
possible that residues at these positions only need to be charged—and perhaps the amino
acid at position 288 needs to specifically be positively-charged—for proper structure and
function of the native AaSPIV protease.
3.2 Recombinant Protein Expression
Growth experiments were performed to determine the optimal conditions for
maximizing soluble recombinant expression of both AaSPII and AaSPIV. As such,
multiple approaches were taken initially to compare various effects on bacterial growth
and recombinant protein expression. This included using different types of media, growth
temperature, induction by IPTG or auto-induction, incorporation of fusion tags like MBP
or a His6-tag, and replacing the propeptide region with an EK-pseudo propeptide.
Initially, growth experiments were conducted with pET28a plasmid constructs to
yield N-terminally His6-tagged recombinant enzymes (AaSPII without leader, AaSPIV
with leader) using SHuffle T7 E. coli cells grown at 10 ºC for a total of 64 h in either LB
media (results not shown) or TB media (See Figures 17 and 18). Effects of recombinant
target protein expression using LB and TB media were assessed but expression with TB
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media was clearly superior (higher expression levels of total recombinant proteases). TB
media (12 g/L tryptone, 24 g/L yeast extract, 9.4 g/L K2HPO4, 2.2 g/L KH2PO4, and
0.4% v/v glycerol) is much richer than LB media (10 g/L tryptone, 5 g/L yeast extract,
and 5 g/L NaCl) and provides more effective buffering against metabolic pH changes due
to the inclusion of monobasic and dibasic potassium phosphate.83 For this reason, growth
experiments using LB media can limit target protein expression due to acid produced via
glucose metabolism surpassing buffering capabilities of LB media and halting cell
growth and protein synthesis.83
Lowering the temperature has been shown to reduce protein aggregation in
difficult-to-express proteins, but at the same time slows bacterial growth and metabolism,
and so to further increase soluble expression, growth times were extended when lower
temperatures used.47 Factors contributing to increased solubility of recombinant proteins
at reduced expression temperatures include the temperature-dependence of hydrophobic
interactions that can lead to protein aggregation and the prevention of bacterial heat
shock protein expression that could otherwise be induced in recombinant overexpression
conditions.47 Additionally, lower temperatures slow the bacterial protein expression
machinery, leading to lower expression rates of proteins and thus more chaperone
proteins are available to aid in proper folding (despite optimal chaperone activity and
expression ~30 ºC).47,83
Another factor that is typically problematic in recombinant protein expression is the
presence of disulfide bonds in the target protein required for proper folding and
solubility; both AaSPII and AaSPIV are predicted to form four disulfide bonds in the
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native conformation, which may not be properly forming during growth
experiments.47,49,84 Because correctly forming the native disulfide bonds between these
eight cysteine residues (of 105 possible isomers) is essential to proper folding, SHuffle
T7 competent E. coli cells were chosen for expression in anticipation of potential
expression difficulties associated with improper folding of disulfide-bonded proteins
because they express the disulfide bond isomerase DsbC, which acts as a chaperone to
aid in protein folding and the correction of mismatched disulfide bonds.47,49,69,84 The
strain also contains deletions of the genes for glutaredoxin reductase and thioredoxin
reductase leading to a more oxidizing cytoplasm and facilitating proper disulfide bond
formation.49,50,69
As shown in Figures 17 and 18, the recombinant enzymes (AaSPII without leader and
AaSPIV with leader) were successfully expressed, but as in insoluble proteins. They were
only found in the total samples, which represent all of the total proteins and enzymes
expressed by the bacterial cells, including the recombinant enzyme of interest.85 No
visible bands corresponding to the enzymes of interest are observed in the soluble
samples. This may be due to misfolding of the target enzymes, which is a common
occurrence for disulfide-bonded proteins and would result as insoluble aggregated
proteins known as inclusion bodies.47 Unfavorable protein-folding conditions caused by
macromolecular crowding can lead to the formation of inclusion bodies, which occurs as
a response to stress caused by high rates of recombinant protein expression.86
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Figure 17. 4-12% BIS-TRIS Gel analysis of samples collected from a 64 h growth experiment of AaSPII-NL-pET28a in
SHuffle T7 E. coli cells grown at 10 ºC using TB media. Lane 1 is the protein Molecular Weight (MW) ladder (Thermo
Scientific PageRuler (in kDa). From left to right, lanes include total and soluble samples at various time-points (labeled by h).
Total samples show target protein expression at the expected MW region (~32 kDa).
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Figure 18. 4-12% BIS-TRIS Gel analysis of samples collected from a 64 h growth experiment of AaSPIV-pET28a in SHuffle
T7 E. coli cells grown at 10 ºC using TB media. Lanes 1 and 8 are the protein Molecular Weight (MW) ladder (Thermo
Scientific PageRuler, in kDa). From left to right, other lanes include total and soluble samples at various time-points (labeled
by h). Total samples show target protein expression at the expected MW region (~32 kDa).
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Additionally, the metabolic burden of recombinant protein expression imparted on
bacterial cells often limits cell growth; growth rates of bacterial cells containing vector
plasmids suffer due to the added strain of plasmid replication and cellular translation and
transcription mechanisms.85,87,88 Therefore, expression via auto-induction was pursued in
an attempt to increase soluble protease expression; because auto-induction techniques
enable bacterial cells to grow to high density before expression is induced, higher total
target protein expression levels can be achieved by limiting the metabolic stress bacterial
cells can undergo during recombinant protein expression.70,71 To determine if this would
be the case for AaSPII (no leader) and AaSPIV (with leader), both enzymes were
expressed under auto-induction conditions (auto-induction media) in SHuffle T7 E. coli
cells at 10 ºC for a total of 96 h (Figures 19 and 20).
Unfortunately, soluble expression of AaSPII (no leader) and AaSPIV (with leader)
using SHuffle T7 cells and auto-induction media (Figures 19 and 20) showed no visible
bands in the expected region associated with the size of target proteins. Both were found
only in the total samples. Additionally, these bands appeared to be less intense (lower
expression) than those associated with expression using TB media and IPTG induction
(Figures 17 and 18). However, initial comparison of the expression of these recombinant
enzymes in TB and in auto-induction media is somewhat misleading: while the
expression level of target protein (based on band intensity) was higher for IPTG-induced
growth samples, the overall yield of all expressed proteins was lower. Because
auto-induced cultures grew to notably higher cell densities, the overall yield of all
expressed proteins was much higher for auto-induced growth samples.70 Because
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recombinant protein expression is suppressed in the auto-induction process until glucose
and glycerol in the media are depleted, cells can grow to high densities without suffering
metabolic stress before recombinant protein production begins. 70Additionally, the rich
auto-induction media (1% N-Z-amine, 0.5% yeast extract, 25 mM Na2HPO4, 25 mM
KH2PO4, 50 mM NH4Cl, 5 mM Na2SO4, 2 mM MgSO4, 0.5% glycerol, 0.05% glucose,
and 0.2% lactose) is designed for higher availability of bacterial nutrient sources as well
as better pH regulation for optimal bacterial cell growth until nutrient sources are
depleted and protein expression is auto-induced by lactose present in the media.70
Although growth experiments under auto-inducing conditions did not seem to promote
soluble protein expression as hoped, increased yields of insoluble target proteins would
be an improvement if later refolding methods are used.47,89 Because refolding techniques
are consistently inefficient, higher initial protein yields would maximize final yields.47,89
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Figure 19. 4-12% BIS-TRIS Gel analysis of samples collected from a 96 h growth experiment of AaSPII-NL-pET28a in
SHuffle T7 E. coli cells grown at 10 ºC using auto-induction. Lane 1 is the protein Molecular Weight (MW) ladder (Thermo
Scientific PageRuler, in kDa). From left to right, other lanes include total and soluble samples at various time-points (labeled
by h). Total samples show target protein expression at the expected MW region (~32 kDa).
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Figure 20. 4-12% BIS-TRIS Gel analysis of samples collected from a 96 h growth experiment of AaSPIV-pET28a in SHuffle
T7 E. coli cells grown at 10 ºC using auto-induction. Lanes 1 and 8 are the protein Molecular Weight (MW) ladder (Thermo
Scientific PageRuler, in kDa). From left to right, other lanes include total and soluble samples at various time-points (labeled
by h). Total samples show target protein expression at the expected MW region (~32 kDa)
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Since the described attempts at expressing soluble recombinant AaSPII and AaSPIV
(media, temperature, and bacterial cells) failed, the decision was made to determine if
modifying the natural propeptide region with an EK-pseudo propeptide region would aid
in the soluble expression of AaSPII by preventing possible autoactivation of the
recombinant enzymes, but also in removing eukaryotic nucleotides rarely found in E.
coli.23,90,91 When foreign mRNA contains excessive codons that are rare in E. coli, less
abundant tRNAs can be depleted, leading to incorporation of the wrong amino acid or
truncation, both of which cause decreased target protein expression levels. The
EK-pseudo propeptide plasmid construct was expressed in SHuffle T7 E. coli cells grown
under two different sets of conditions: (1) auto-induced and grown in auto-induction
media at 30 ºC for 24 h (Figure 21) or (2) induced by IPTG and grown in TB media at
15 ºC for 72 h (Figure 22).
It has been proposed that the lack of an enterokinase cleavage site in the zymogen
form of Ae. aegypti trypsin-like serine proteases homologous to mammalian trypsinogen
is indicative of autocatalytic behavior; but, this has not yet been shown definitively.44
Additionally, other abundant Ae. aegypti serine proteases of study in the Rascón lab have
been shown to be autocatalytic (results not published). Incorporation of the EK-pseudo
propeptide region at the N-terminus of express recombinant target proteins was
performed for two main purposes: (1) to overcome potential autoactivation of
recombinant AaSPII or AaSPIV proteases in addition to autodigestion and thus contribute
to difficulties in obtaining soluble expression and (2) to facilitate in vitro activation post
purification.23
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Figure 21. 4-12% BIS-TRIS Gel analysis of samples collected from a 24 h growth experiment of EK-AaSPII-pET28a in
SHuffle T7 E. coli cells grown at 30 ºC using auto-induction. Lanes 1 and 8 are the protein Molecular Weight (MW) ladder
(Thermo Scientific PageRuler, in kDa). From left to right, other lanes include total and soluble samples at various time-points
(labeled by h). Total and soluble samples show target protein expression at the expected MW region (~32 kDa).
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Figure 22. 4-12% BIS-TRIS Gel analysis of samples collected from a 72 h growth experiment of EK-AaSPII-pET28a in
SHuffle T7 E. coli cells grown at 15 ºC using auto-induction. Lane 1 is the protein Molecular Weight (MW) ladder (Thermo
Scientific PageRuler, in kDa). From left to right, other lanes include total and soluble samples at various time-points (labeled
by h). Total samples show target protein expression at the expected MW region (~32 kDa).
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SDS-PAGE results from the two growth experiments (Figure 21, Figure 22) to
express the EK-pseudo propeptide plasmid construct did not show high expression levels
in either total or soluble samples. However, soluble expression of AaSPII with the
EK-pseudo propeptide at 30 ºC using auto-induction media (Figure 21) was observed in
the predicted region of the gel (~32 kDa). Since growth under 30 ºC auto-induction
conditions showed some soluble target protein expression (Figures 21 and 23), the
growth experiment was repeated but, rather than grow at 30 ºC only, the temperature was
lowered to 15 ºC after reaching an OD600 of approximately 0.8 in an effort to increase
soluble expression; unfortunately, there was no visible expression in SDS-PAGE or
Western blot analyses of later growth experiments using auto-induction methods
performed at 15 ºC (results not shown). Because the growth temperature was lowered in
an attempt to increase soluble expression, a loss of soluble expression at lower
temperatures (Figure 20) was unexpected. However, this may be due to bacterial protein
chaperone activity and expression, which is typically optimal in E. coli at 30 ºC.47 While
heat shock proteins can function as chaperones at high temperatures, cold shock proteins
typically function as RNA chaperones at low temperatures.92,93 Additionally, beneficial
effects of low growth temperatures can become overwhelmed by the lowered
transcription and translation efficiency of E. coli. 92,93
In order to determine if low levels of soluble AaSPII with the EK-pseudo propeptide
(Figure 20) were expressed at 30 ºC using auto-induction techniques and confirm if bands
associated with total samples in the appropriate molecular weight region could indeed be
attributed to target protein expression, analysis of growth experiment time-points by
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Western blot was performed (Figure 23). Because Western blotting uses antibody-antigen
interactions to visualize expression of the target protein, it is a much more specific and
sensitive technique (compared to visualization by SDS-PAGE, which is not specific for a
particular protein); eliminating visualization of non-specific background bacterial protein
expression would increase confidence in confirming expression of the target protein.42
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Figure 23. Western blot analysis of samples collected from a 24 h growth experiment of EK-AaSPII-pET28a in SHuffle T7 E.
coli cells grown at 30 ºC using auto-induction. Lane 1 is the protein Molecular Weight (MW) ladder (Thermo Scientific
PageRuler, in kDa). From left to right, other lanes include total and soluble samples at various time-points (labeled by h). Total
and soluble samples show target protein expression at the expected MW region (~32 kDa).
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As shown in Figure 23, Western blot analysis revealed successful expression of the
His6-tagged protein at low levels in both total and soluble fractions. In the later
time-point samples (taken at 18 and 24 h), there are also bands present in lower molecular
weight regions. This may indicate that, despite incorporation of the EK-pseudo
propeptide region, the expressed proteins have autoactivated and begun autodigesting,
resulting in the presence of smaller molecular weight peptides containing the His6-tag. If
this is the case for AaSPII and AaSPIV, despite incorporation of the EK-pseudo
propeptide, it may be due to the presence of the lysine residue at the cleavage site, which
is also present in the wild-type protease; if autoactivation of the proteases is facilitated by
the presence of the lysine residue (which is consistent with trypsin substrate specificity),
incorporation of the EK cleavage site (DDDDK) would not prevent autoactivation.94
Aside from the amino sequence of the propeptide region, one factor that can contribute to
autoactivation of mammalian trypsinogen includes modification of the protein surface
charge since autoactivation is promoted by protein-protein interactions.95
Additionally, comparison of the SDS-PAGE results (Figure 21) with the
complementary Western blot (Figure 23) for expression of AaSPII containing the EKpsuedo propeptide region in SHuffle T7 E. coli cells grown at 30 ºC under auto-induction
conditions shows that, despite achieving soluble expression, the expression level (band
intensity) of the target protein is similar to expression levels of bacterial proteins.
Because target protein yields were relatively minimal, the AaSPII (no leader) and
full-length AaSPIV (with leader) genes were each cloned into the pMAL-c5E vector for
expression of the protein using the pET28a plasmid constructs as templates. Expressing

71

recombinant enzymes as MBP-tagged proteins has been shown dramatically increase the
expression levels of soluble recombinant proteins and use of this method was performed
in hopes of achieving similar results for AaSPII (no leader) and full length AaSPIV (with
leader).47 Using the pET28a plasmid constructs as templates for insertion allowed for
incorporation of the His6-tag between the N-terminal MBP and C-terminal recombinant
enzyme (Figure 13); incorporation of the His6-tag should not interfere with expression.96
Additionally, the use of MBP and the His6-tag provide two potential downstream
methods of purification (exploitation of MBP-amylose binding or of metal affinity to the
His6-tag); optimal purification methods for obtaining the higher purified protein yields
can be determined by using one or both of the two methods.96 In many previous
instances, MBP for high soluble expression levels in combination with the robust method
IMAC method of purification has been shown to be very effective for difficult-to-express
proteins.96
MBP-tagged AaSPII without the leader sequence (MBP-AaSPII) and MBP-tagged
full length AaSPIV with the leader sequence (MBP-AaSPIV) were expressed in LB
media at 15 ºC for 24 h (MBP-AaSPII; Figure 24) or for 48 h (MBP-AaSPIV; Figure 25).
Additionally, to determine if soluble expression could be increased by altering growth
time, temperature, and media, the growth experiment to express MBP-AaSPIV was
repeated using the AaSPIV-pMAL plasmid construct in SHuffle T7 cells grown in TB
media at 12 ºC for 77 h; results were assessed via His-Stain procedure to reduce
visualization of background protein expression in the gel (Figure 26).
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Figure 24. 4-12% BIS-TRIS Gel analysis of samples collected from a 24 h growth experiment of AaSPII-pMAL-c5E in
SHuffle T7 E. coli cells grown at 15 ºC using LB media. Lanes 1 and 7 are the protein Molecular Weight (MW) ladder
(Thermo Scientific PageRuler, in kDa). From left to right, other lanes include total and soluble samples at various time-points
(labeled by h). Total and soluble samples show target protein expression at the expected MW region (~75 kDa).
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Figure 25. 4-12% BIS-TRIS Gel analysis of samples collected from a 48 h growth experiment of AaSPIV-pMAL-c5E in
SHuffle T7 E. coli cells grown at 15 ºC using LB media. Lanes 1 and 8 are the protein Molecular Weight (MW) ladder
(Thermo Scientific PageRuler, in kDa). From left to right, other lanes include total and soluble samples at various time-points
(labeled by h). Total and soluble samples show target protein expression at the expected MW region (~75 kDa).
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Figure 26. 4-12% BIS-TRIS Gel analysis of soluble samples collected from a 77 h growth experiment of AaSPIV-pMAL-c5E
in SHuffle T7 E. coli cells grown at 12 ºC using TB media. Lane 1 is the protein Molecular Weight (MW) ladder (Thermo
Scientific PageRuler, in kDa). From left to right, other lanes include soluble samples at various time-points (labeled by h).
Samples show target protein expression at the expected MW region (~75 kDa).
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As expected, growth experiments with MBP-tagged recombinant enzymes (Figures
24, 25, and 26) significantly increased expression levels in both total and soluble
samples. Results showed that expression of pMAL-c5E plasmid constructs in SHuffle T7
cells grown at 15 ºC in LB media (Figures 24 and 25) resulted in similar expression of
MBP-AaSPII and MBP-AaSPIV as compared to growth in TB media (results not shown).
Expression with the MBP-fusion tag using LB media seemed to be sufficient; potential
buffering problems with LB that could lead to poor soluble target protein yield were
counterbalanced by the improved expression due to the MBP-fusion tag while expression
of background bacterial proteins was limited, which could aid in downstream purification
processes, and so LB media was used to express MBP-AaSPII or MBP-AaSPIV in later
growths.83
Extending growth times also did not seem to significantly increase soluble protein
expression; expression of pMAL-c5E plasmid constructs in SHuffle T7 E. coli cells at
15 ºC in LB media for 24 h (MBP-AaSPII; Figure 24) or for 48 h (MBP-AaSPIV; Figure
25) were sufficient to maximize soluble target protein yields as predicted, due to the
robustness of the MBP-fusion tag for use as a solubility enhancer.47,96
3.3 Initial Purification Attempts and Qualitative Activity Assay
For both enzymes (AaSPII without the leader sequence and AaSPIV with the leader
sequence), expression using the MBP-fusion tag (pMAL-c5E plasmid constructs) resulted
in soluble recombinant protein expression; and so, this method was used for large-scale
protein expression for purification. As mentioned, one benefit of using the pMAL-c5E
plasmid constructs is that we were able to clone the genes with the N-terminal His6-tag in
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place, thereby creating the MBP-fusion protein (Figure 13), both of which can be
exploited in the purification process.96 Initial purification attempts of MBP-AaSPIV (with
leader) were performed using the wheat starch purification protocol previously outlined.
Unfortunately, SDS-PAGE analysis of fractions obtained throughout the purification
process indicated purification was unsuccessful (Figure 27). SDS-PAGE results show a
visible band of appropriate size and intensity associated with the total sample; however,
the band is no longer visible in the soluble sample or in any of the later flow through or
elution samples (see Figure 27).

Figure 27. 4-12% BIS-TRIS Gel analysis of fractions collected from wheat starch
purification of MBP-AaSPIV recombinant protease expressed in SHuffle T7 cells grown
at 15 ºC for 48 h in LB media. Lane 1 is the protein Molecular Weight (MW) ladder
(Thermo Scientific PageRuler, in kDa). From left to right, other lanes include total and
soluble samples three subsequent flow through samples (FT 1, FT 2, and FT3), and the
elution sample. Only the total sample shows target protein expression at the expected
MW region (~75 kDa).
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The observed absence of MBP-AaSPIV in the soluble fractions (Figure 27), despite
evident soluble expression in the large-scale growth (Figure 25), suggests that the
MBP-fusion proteases may be autoactivating.44 Interestingly, results of the His-Stain
procedure used to visualize expression of the His6-tagged MBP-AaSPIV recombinant
fusion protein revealed potential autoactivation at low levels due to the presence of a
protein species at around 50 kDa (Figure 26). From the His-Stained gel, high levels of
soluble expression are observed at the expected molecular weight of ~75 kDa, but upon
careful analysis, the presence of faint bands at the lower molecular weight (~50 kDa)
becomes evident. The major reason visualization by His-Stain is used is because this stain
eliminates bands associated with background bacterial protein expression, especially
those that lack the His6-tag, therefore making it easier to distinguish between native
bacterial proteins and the target His6-tagged recombinant enzymes.
Autoactivation leading to cleavage at the predicted cleavage site would result in free,
active soluble recombinant AaSPIV (MW ~28 kDa) and free His6-tagged MBP (MW ~47
kDa) (see scheme in Figure 28) (combined MW of the fusion protein ~75 kDa),
effectively preventing purification of the target enzyme using wheat starch, which has a
fair amount of amylose. As mentioned, MBP will naturally bind to amylose, and it is
expected that free MBP should be visible in the elution fraction after the addition of
maltose. However, there is nothing visible in the elution sample (Figure 27), which may
support the autoactivation of AaSPIV, in which this active protease is cleaving and
digesting the His6-tagged MBP.44
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Figure 28. Scheme showing cleavage of the MBP–His6-tag–Protein fusion product
following autoactivation, resulting in free His6-tagged MBP and free active target protein.
Initial failed attempts using the wheat starch batch purification method prompted
purification trials using ion exchange chromatography to remove contaminants and purify
based on the pI of the MBP-fusion protease. Typically, multiple purification steps are
performed in succession to recover pure target proteins; in these cases, inclusion of the
MBP (which can bind to wheat starch and amylose resin) and the His6-tag (recoverable
via IMAC) presents possibilities for future purification steps in addition to other options
such as size-exclusion chromatography.96 However, since the initial wheat starch method
was unsuccessful, ion exchange was attempted using the following specifications:
MBP-AaSPII and MBP-AaSPIV expressed in SHuffle T7 cells grown at 15 ºC for 48 h in
LB media purified via FPLC using a DEAE (weak) anion exchange column in 20 mM
Tris-HCl, pH 8 buffer (Figures 29 and 30).
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Figure 29. 4-12% BIS-TRIS Gel analysis of fractions collected from purification via FPLC using DEAE anion exchange
column in 20 mM Tris-HCl, pH 8 buffer of MBP-AaSPII recombinant protease expressed in SHuffle T7 cells grown at 15 ºC
for 48 h in LB media. Lanes 1 and 21 are the protein Molecular Weight (MW) ladder (Thermo Scientific PageRuler, in kDa).
From left to right, other lanes include total and soluble samples, two subsequent flow through samples (FT 1 and FT 2), and
elution samples labeled according to the corresponding location in the 96-well collection microplate. Only the total sample
shows target protein expression at the expected MW region (~75 kDa).
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Figure 30. 4-12% BIS-TRIS Gel analysis of fractions collected from purification via FPLC using DEAE anion exchange
column in 20 mM Tris-HCl, pH 8 buffer of MBP-AaSPIV recombinant protease expressed in SHuffle T7 cells grown at 15 ºC
for 48 h in LB media. Lanes 1 and 23 are the protein Molecular Weight (MW) ladder (Thermo Scientific PageRuler, in kDa).
From left to right, other lanes include total and soluble samples, two subsequent flow through samples (FT 1 and FT 2), and
elution samples labeled according to the corresponding location in the 96-well collection microplate. Only the total sample
shows target protein expression at the expected MW region (~75 kDa).
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Initial results from the anion exchange purification of MBP-AaSPII and
MBP-AaSPIV recombinant enzymes (Figures 29 and 30) were similar to those observed
using the wheat starch purification method (Figure 27): a band of the correct size and
intensity (~75 kDa) is visible in the total sample (indicative of the MBP-fusion target
enzyme), but not present in the soluble sample or in later fractions taken throughout the
flow through or elution process. This outcome, in combination with corresponding
previous results of wheat starch purification methods, provides consistent evidence in
support of the potential autocatalytic behavior of AaSPII and AaSPIV.44 In an attempt to
confirm if autoactivation and/or autodigestion of the recombinant enzymes is indeed
occurring, analysis of FPLC fractions by Western blotting was performed to locate any
cleaved His6-tagged peptides in the fractions (Figure 31).
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Figure 31. Western blot analysis of fractions obtained from purification attempt via FPLC using DEAE anion exchange
column in 20 mM Tris-HCl, pH 8 buffer of MBP-AaSPIV expressed in SHuffle T7 cells grown at 15 ºC for 48 h in LB media.
Lane 1 is the protein Molecular Weight (MW) ladder (Thermo Scientific PageRuler, in kDa). From left to right following the
ladder, lanes include total and soluble samples, two subsequent flow through samples (FT 1 and FT 2), and elution samples
labeled according to the corresponding location in the 96-well collection microplate. Total, soluble, and fractions B8, B12, and
C4 show His6-tagged protein expression at a much lower MW region than expected (~50 kDa observed, ~75 kDa expected).
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Results of the Western blot (Figure 31) from collected purified fractions of
MBP-AaSPIV using DEAE clearly show a protein species with a His6-tag in the soluble
sample and in later elution fractions at a much lower molecular weight than anticipated
(~50 kDa observed, rather than the ~75 kDa that is expected). This provided further
evidence that the enzyme is autocatalyzing at the propeptide cleavage region resulting in
the loss of the His6-tag on the target protease, but cleaving the site to remain on the MBP
(Figure 28). This initial hypothesis is based on amino acid sequence analysis suggesting
the likely location of protein cleavage leading to autoactivation: two protein species
would potentially be produced: MBP with the His6-tag and propeptide region of the
enzyme (~47 kDa) and the active, recombinant enzyme (~28 kDa for both AaSPII and
AaSPIV). The only probable conclusion that can be made is that autoactivation is
occurring during the purification process, leading to free, activated AaSPIV recombinant
enzyme (as shown in the scheme depicted in Figure 28) and the MBP with the His6-tag
on the C-terminus.44 Overlaying the results of the Western blot (Figure 31) with those of
the complementary SDS-PAGE (Figure 30) shows very clearly in which purification
fractions the cleaved His6-tagged protein appears and at what approximate concentrations
based on band intensity (Figure 32).
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Figure 32. Overlay of Western blot (Figure 31) and complementary SDS-PAGE (Figure
30) performed on fractions obtained from purification attempt via FPLC using DEAE
anion exchange column in 20 mM Tris-HCl, pH 8 buffer of AaSPIV-pMAL expressed in
SHuffle T7 cells grown at 15 ºC for 48 h in LB media.
The results observed from the wheat starch and anion exchange purification is not at
all too surprising since mammalian trypsins have been shown to autoactivate at slightly
alkaline conditions (pH ~7–9) and can digest other proteins in the cytosol once active.46
In addition, AaSPII and AaSPIV, as well as other Ae. aegypti serine proteases, lack the
enterokinase cleavage site present in mammalian trypsins (the main autocatalytic
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regulation mechanism) indicating that autoactivation is the likely mechanism responsible
for activation of these digestive mosquito enzymes.22,36,44,46,61 Thus far, the Rascón lab
has successfully determined that the most abundant midgut proteases are indeed
autocatalytic (unpublished results).
While autoactivation of the MBP-fusion recombinant proteases presents extensive
purification challenges, it indicates that the recombinant target enzymes are properly
folded and active. Thus, based on these results, we can confidently suggest that
successful soluble expression was achieved and the native disulfide bonds found in
AaSPII and AaSPIV were successfully formed in the folding process. While it also seems
reasonable to expect that the bulky MBP-fusion tag might inhibit autoactivation (which
depends on successful protein-protein contacts) and any subsequent enzyme activity, this
was surprisingly not the case. However, previous literature does implicate that other
enzymes expressed with an MBP-fusion tag have also been shown to retain activity
comparable to the free, active enzyme and were not inhibited by the presence of the
MBP-fusion protein.95,97-99 In order to confirm the presence of trypsin activity in any of
the fractions and to determine which fractions might contain the target proteases, a
qualitative enzyme activity assay using the chromogenic trypsin peptide substrate analog
BApNA was performed on each DEAE purified fraction, as described in the Methods
section. As shown in Figure 33, the soluble fraction and later elution fractions
(corresponding to C6–D5, Figure 30) were positive for trypsin activity (yellow).
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Figure 33. Qualitative enzyme activity assay reaction samples using BApNA to detect the presence of trypsin-like activity in
fractions collected from purification via FPLC using DEAE anion exchange column in 20 mM Tris-HCl, pH 8 buffer of
AaSPIV-pMAL expressed in SHuffle T7 cells grown at 15 ºC for 48 h in LB media. From left to right and top to bottom,
reaction samples are the soluble fraction and elution samples labeled according to the corresponding location in the 96-well
collection microplate. A yellow color indicative of trypsin-like activity is visible in the soluble sample and in reaction tubes
labeled C6, C8, C11, D2, and D5.
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While no negative control is shown here, similar assays have been performed by
members of the Rascón lab using total and soluble bacterial protein samples without
expression of the recombinant serine proteases resulting in no color change or indication
of trypsin activity. Confirmation of trypsin activity in purification fractions seems
promising but also indicates further challenges associated with obtaining purified
enzyme. Specifically, cleavage at the predicted cleavage site results in free, active
enzyme without the His6-tag or MBP attached, both of which could have been used to
facilitate further purification steps.96 Additionally, the lack of any bands present with
high intensity at the appropriate size (~28 kDa) is likely due to autodigestion, which
would likely begin immediately following activation.46 Potential autodigestion of AaSPII
and AaSPIV in addition to autoactivation further contributes to difficulties associated
both with purifying the enzymes and downstream experiments to perform activity assays
and obtain kinetic data.44
3.4 Alternative Purification Approaches
In an effort to achieve purification of the recombinant enzymes, while preventing
previously observed autoactivation and autodigestion, several alternative purification
approaches will be pursued. Previous purification methods used buffers with pH values
within the same range as that associated with optimal trypsin activity (pH 7–8).41 Since
enzyme activity is often dependent on pH, later purification processes will use low pH
buffer systems in an effort to prevent the recombinant proteases from being active and
avoid autoactivation that may occur during the purification preparation process.41 An
initial attempt using this strategy focused on two cation exchange columns: (1) a CM
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weak cation exchange column using 50 mM sodium acetate, pH 5.2 to purify
MBP-AaSPII expressed in SHuffle T7 cells grown at 15 ºC for 48 h in LB media (Figure
34) and (2) an SP strong cation exchange column using 50 mM acetic acid, pH 4.3 buffer
to purify MBP-AaSPIV expressed in SHuffle T7 cells grown at 15 ºC for 48 h in LB
media (Figure 35).
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Figure 34. 4-12% BIS-TRIS Gel analysis of fractions collected from purification via FPLC using a CM weak cation exchange
column in 50 mM sodium acetate, pH 5.2 buffer of MBP-AaSPII expressed in SHuffle T7 cells grown at 15 ºC for 48 h in LB
media. Lanes 1 and 17 are the protein Molecular Weight (MW) ladder (Thermo Scientific PageRuler, in kDa). From left to
right, other lanes include total and soluble samples, two subsequent flow through samples (FT 1 and FT 2), and elution
samples labeled according to the corresponding location in the 96-well collection microplate. Total, soluble, and the first flow
through (FT 1) samples show target protein expression at the expected MW region (~75 kDa).
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Figure 35. 4-12% BIS-TRIS Gel analysis of fractions collected from purification via
FPLC using a SP cation exchange column in 50 mM acetic acid, pH 4.3 buffer of
MBP-AaSPIV expressed in SHuffle T7 cells grown at 15 ºC for 48 h in LB media. Lane
1 is the protein Molecular Weight (MW) ladder (Thermo Scientific PageRuler, in kDa).
From left to right, other lanes include total and soluble samples, two subsequent flow
through samples (FT 1 and FT 2), and elution samples labeled according to the
corresponding location in the 96-well collection microplate. Total, soluble, and the first
flow through (FT 1) samples show target protein expression at the expected MW region
(~75 kDa).
Analysis of fractions collected throughout the purification using these two cation
exchange strategies [(1) CM weak cation exchange (Figure 34) and (2) SP strong cation
exchange (Figure 35)] suggest that the recombinant, MBP-tagged enzymes remain
soluble and do not autoactivate at low pH. However, the MBP-fusion proteins of interest
eluted in the flow through (FT 1) indicating that the fusion proteins did not interact with
either column. Interestingly, it appears that using pH 5.2 is enough to reduce and
potentially eliminate protease autoactivation, resulting in a more positively-charged
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histidine residue in the active, which would no longer act as an effective proton acceptor
to generate the active site serine alkoxide ion needed for catalytic activity.42 While
autoactivation appears to have been prevented, it also seems that other bacterial proteins
in the lysate have also eluted in the flow through; despite the enzymes remaining inactive
during both purification attempts (Figures 34 and 35), purification at low pH does not
seem to be an effective method of removing excess bacterial proteins. Perhaps in
combination with other purification methods, this could be used for an initial, crude
purification step or purification attempts with even lower pH buffers could be used with a
strong cation exchange column. Since the MBP-fusion complex has a calculated pI value
of 5.50 (MBP-AaSPII) or 5.38 (MBP-AaSPIV), lowering the pH even further to achieve
tighter binding of the complex to the column would result in a later elution time for the
complex.
Because purification via FPLC using DEAE anion exchange column in 20 mM TrisHCl, pH 8 buffer of MBP-tagged AaSPII or AaSPIV (Figures 29 and 30) resulted in both
the MBP and the recombinant enzymes eluting in later fractions (not the flow through), it
may be a more effective method of purification, only if autoactivation can be prevented.
Therefore, this purification procedure was re-attempted under the same conditions with
the addition of 1 mM phenylmethylsulfonyl fluoride (PMSF) to the crude lysate
preparation. PMSF is an irreversible, covalent serine protease inhibitor and adding it to
the purification buffer should prevent any potential autoactivation and subsequent
digestion from occurring. Results of this purification were assessed via SDS-PAGE
(Figure 36) and Western blot (Figure 37).
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Figure 36. 4-12% BIS-TRIS Gel analysis of fractions collected from purification via FPLC using DEAE anion exchange
column in 20 mM Tris-HCl, pH 8 buffer of MBP-AaSPIV recombinant protease expressed in SHuffle T7 cells grown at 15 ºC
for 72 h in LB media and prepared with 1 mM PMSF added to the crude lysate preparation. Lanes 1 and 24 are the protein
Molecular Weight (MW) ladder (Thermo Scientific PageRuler, in kDa). From left to right, other lanes include total and soluble
samples, two subsequent flow through samples (FT 1 and FT 2), and elution samples labeled according to the corresponding
location in the 96-well collection microplate. Only the total sample shows target protein expression at the expected MW region
(~75 kDa).
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Figure 37. Western blot analysis of fractions obtained from purification attempt via FPLC using DEAE anion exchange
column in 20 mM Tris-HCl, pH 8 buffer of MBP-AaSPIV (with leader) expressed in SHuffle T7 cells grown at 15 ºC for 72 h
in LB media and prepared with 1 mM PMSF added to the crude lysate preparation. Lane 1 is the protein Molecular Weight
(MW) ladder (Thermo Scientific PageRuler, in kDa). From left to right following the ladder, lanes include total and soluble
samples, two subsequent flow through samples (FT 1 and FT 2), and elution samples labeled according to the corresponding
location in the 96-well collection microplate. Total, soluble, and fractions B5, B9, C2, and C7 show His6-tagged protein
expression at a much lower MW region than expected (~50 kDa observed, ~75 kDa expected).
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As shown in Figures 36 and 37, results from this purification of MBP-AaSPIV (with
leader, expressed in SHuffle T7 cells grown at 15 ºC for 72 h in LB media via FPLC
using a DEAE weak anion exchange column in 20 mM Tris-HCl, pH 8 buffer with the
addition of 1 mM PMSF to the crude lysate preparation) were quite unexpected: analysis
of sample fractions shows that cleavage of the MBP-tagged protein still occurs despite
addition of PMSF, yielding a His6-tagged protein region consistent in size with the 47
kDa His6-tagged MBP expected after autoactivation. PMSF is an effective irreversible
serine protease inhibitor so it is unclear why this recombinant enzyme would remain
active after addition of PMSF to the purification buffer and appear to have no effect on
limiting autoactivation. However, it has been suggested that PMSF is not as specific for
serine proteases as is often assumed and there are examples of serine proteases that are
not inhibited by PMSF.100 Results from a qualitative activity assay (not shown) using
BApNA showed that trypsin activity in fractions associated with this purification attempt
(Figure 36) was not inhibited by the presence of PMSF. Also, predictions of protease
function based on sequence analyses are sometimes found to be incorrect upon obtaining
experimental functional data so it may be possible that AaSPII or AaSPIV are not
trypsin-like enzymes despite sequence alignments suggesting so; while sequence analyses
can be powerful tools for designing experimentation and predicting results, assumptions
based on sequence homology assessments are somewhat uncertain until enzyme function
and structure are experimentally determined.82,101 Previous study of one of the abundant
Ae. aegypti serine proteases, late trypsin (AaLT), found that, despite identification of
AaLT as a trypsin based on deduced amino acid sequence and sequence alignment data,
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reduction of AaLT transcripts did not result in a loss of trypsin-like activity, as was
predicted.22 It was later determined that AaLT lacked the necessary aspartate residue at
position 189 necessary for substrate recognition and specificity of trypsins and, based on
structural modeling data, AaLT is likely to be more accurately defined as a serine
collagenase and not a classic trypsin.23,35
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CHAPTER 4: CONCLUSIONS
4.1 AaSPIV Genome Sequence
Initial attempts taken to isolate the AaSPIV gene from Ae. aegypti cDNA led to the
presence of two specific nucleotide changes that resulted in specific amino acid changes
with respect to the annotated sequence at position 162 (a lysine to a glutamate residue)
and at position 288 (a lysine to an arginine).35 Repeating the isolation of the AaSPIV
gene from a freshly prepared batch of Ae. aegypti whole body mosquito cDNA confirmed
that these changes are indeed consistent with results from initial cloning attempts. This
indicated potential misannotation of the gene sequence in public databases or differences
due to genetic variability of the Ae. aegypti species; it is possible that these two residues
are nonessential for function or flexible in the electrostatic or steric property requirements
for proper folding and activity and therefore are not highly conserved. Hence, these
specific inconsistencies between the AaSPIV gene sequence cloned into each plasmid
construct and the annotated AaSPIV gene sequence were disregarded for all later
experiments and studies herein proceeded; upon solving the structure of AaSPIV, the
identity of these two amino acid residues may be confirmed and their role in the
enzyme’s structure and function can be further assessed to determine if they are expected
to be highly conserved.
4.2 Recombinant Protein Expression
All growth experiments were performed using SHuffle T7 E. coli cells to aid in
proper folding of recombinant AaSPII or AaSPIV. Both of these mosquito proteases are
predicted to contain four disulfide bonds and this engineered bacterial species is designed
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to have a more oxidized cytosolic environment and it expresses a disulfide bond
isomerase (DsbC) to aid in forming native disulfide bonds when cysteine residues are
mis-bonded.69 Several growth experiment conditions resulted in the insoluble expression
of the target enzymes: AaSPII (no leader)-pET28a construct (N-terminally His6-tagged)
grown at 10 ºC using TB media (Figure 17) or in auto-induction media (Figure 19);
AaSPIV (with leader)-pET28a construct (N-terminally His6-tagged) grown at 10 ºC in TB
media (Figure 18) or in auto-induction media (Figure 20); and AaSPII-pET28a with the
EK-pseudo propeptide region construct (N-terminally His6-tagged) grown at 15 ºC in
auto-induction media (Figure 22). Surprisingly, when this construct was grown at a
higher temperature (30 ºC for 24 h) soluble expression was observed (Figure 23).
Additionally, total expression levels for each of these growth experiments did not appear
to be very high compared to the naturally expressed bacterial proteins. In biochemically
studying a target protein, large yields of solubly expressed protein are necessary since
large quantities are required for activity assays or structure determination. Therefore,
further experimentation was performed in an attempt to achieve solubly expressed
AaSPII and AaSPIV recombinant proteases.47
After a multitude of growth experiments aimed at optimizing conditions for
recombinant protein expression, I was able to establish a highly effective method for
expressing significant concentrations of soluble recombinant proteases. For both AaSPII
(no leader) and AaSPIV (with leader), soluble recombinant protein expression was
achieved by expressing each enzyme as an MBP-fusion tag using the pMAL-c5E vector.
Specifically, soluble expression was maximized using the following conditions:
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MBP-tagged AaSPII without the leader sequence (MBP-AaSPII) and MBP-tagged full
length AaSPIV with the leader sequence (MBP-AaSPIV) were expressed using SHuffle
T7 E. coli cells grown in LB media at 15 ºC for 24 h (MBP-AaSPII; Figure 24) or for
48 h (MBP-AaSPIV; Figure 25). Growth experiments using the pMAL-c5E constructs
were consistently successful in producing high levels of total and soluble target protein
and were not drastically affected by lowering the growth temperature as far as 10 ºC or
extending growth times to up to 96 h (results not shown). For these reasons, we focused
on the soluble expression of the MBP-fusion proteases for later purification experiments.
4.3 Possible Autocatalytic Activity of AaSPII and AaSPIV
Purification attempts seem to indicate that AaSPII and AaSPIV may be
autoactivating44: (1) results of the SDS-PAGE analysis of fractions collected from the
purification of MBP-AaSPIV using the wheat starch purification method (Figure 27); (2)
results of the SDS-PAGE analysis of fractions collected from the purification of
MBP-AaSPII via FPLC using a DEAE anion exchange column in 20 mM Tris-HCl, pH 8
buffer (Figure 29); and (3) results of the SDS-PAGE (Figure 30) and (4) Western blot
(Figure 31) analyses of fractions collected from the purification of MBP-AaSPIV via
FPLC using a DEAE anion exchange column in 20 mM Tris-HCl, pH 8 buffer. It is also
likely that the proteases undergo autodigestion in addition to autoactivation. Trypsin
activity was observed using the qualitative activity assay with BApNA (Figure 33) to
assess fractions collected from the purification of MBP-AaSPIV via FPLC using a DEAE
anion exchange column in 20 mM Tris-HCl, pH 8 buffer, but in the complementary
SDS-PAGE analysis (Figure 30) there were no discernable bands present in the expected
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region of the gel associated with the free, active protease (~28 kDa), suggesting
autodigestion. This, in combination with the known challenges associated with
expressing disulfide-bonded proteins in E. coli49, would explain much of the difficulty
experienced in both the expression and the purification processes. Despite challenges
presented in attempts to purify the recombinant enzymes, the results of purification
experiments are suggestive of both autocatalysis and autodigestion. Additionally,
purification attempts using lower pH buffers indicate the pH-dependence of protease
activity. While purified proteases were not obtained for use in kinetic or structural
studies, the potential autocatalysis, autodigestion, and pH-dependence of these proteases
provide further insight into the potential roles of AaSPII and AaSPIV in Ae. aegypti
blood meal digestion; because these enzymes are expressed constantly following blood
meal acquisition35, we hypothesize that they may be responsible for the initial digestion
of blood meal proteins to promote accessibility of internal peptide bonds for further
digestion by other midgut serine proteases.
4.4 Future Studies
Due to difficulties in obtaining purified recombinant proteases, which are likely due
to autoactivation and autodigestion during the purification preparation process,
immediate future studies will focus on growth experiments to express recombinant
AaSPII (no leader) and AaSPIV (with leader) with the mutated active site serine to
alanine using both pET28a and pMAL-c5E constructs. This should lead to inactive
proteases incapable of autoactivating and autodigesting and prevent the associated
obstacles observed during the purification of the wildtype AaSPII and AaSPIV fusion
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proteins. However, mutating the active site serine residue would lead to inactive
proteases, making downstream kinetic assays impossible, but could be useful for
obtaining structural data.
Additionally, primers were developed to mutate the lysine residue to alanine at the
propeptide region. This region is necessary in order to convert the inactive zymogen to
the active mature enzyme, and for both AaSPII and AaSPIV, the propeptide cleavage
amino acid is lysine. By mutating this lysine residue, this may prevent autoactivation and
allow for later in vitro activation of the enzyme for functional studies.
Expression of the recombinant enzymes with the engineered EK-pseudo propeptide
was also attempted to prevent autoactivation; however, trypsin-like enzymes prefer to
cleave on the C-terminal peptide bonds of lysine or arginine residues, so the EK region
may still be a suitable target for AaSPII and AaSPIV autoactivation. However, results of
AaSPII with the EK-pseudo propeptide construct in SHuffle T7 cells grown using autoinduction at 30 ºC did show successful expression with limited or no autoactivation
(Figure 21). However, repeated growth experiments using the same conditions or with
lowered temperatures and extended growth times were all unsuccessful (results not
shown). Further efforts to repeat the successful soluble expression observed in Figure 21
need to be taken. Issues obtaining soluble expression of the proteases containing the
EK-pseudo propeptide could likely be overcome with the addition of an MBP-fusion tag.
Each of the pET28a plasmid constructs encoding AaSPII and AaSPIV with the attached
EK-pseudo propeptide can be used as templates for cloning into the pMAL-c5E vector as
described in the Methods section for the AaSPII (no leader) and AaSPIV (with leader)
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constructs. This would allow for expression of MBP-tagged recombinant proteases with
both an internal His6-tag and EK-pseudo propeptide region, which would hopefully result
in highly expressed inactive recombinant enzymes that could be easily purified and later
activated in vitro (this step could be used to both activate the enzyme and also remove the
attached MBP and His6-tag). In order to fully understand the biological role of AaSPII
and AaSPIV in the Ae. aegypti blood meal digestion process, it will be necessary to
circumvent certain difficulties in the expression process in order to obtain kinetic data
and provide insight into the enzymes’ functions.
Of the discussed experiments, purification via FPLC using a DEAE weak anion
exchange column in 20 mM Tris-HCl, pH 8 buffer with the addition of 1 mM PMSF
needs to be repeated with both MBP-tagged proteases to confirm consistency and
repeatability of the results, especially based on the potential implications of ineffective
inhibition of these proteases by PMSF. At this point, purification with PMSF added was
only performed once and only with MBP-tagged AaSPIV (with leader). Because PMSF is
an irreversible inhibitor of serine proteases, its use in the purification process would
prevent later activity studies (as is the case for potential expressed proteases with an
active site serine mutated to an alanine). Therefore, these methods could be used to obtain
inactive but properly folded recombinant enzymes suitable for structural studies via
crystallography. Additionally, purified inactive soluble recombinant proteases could be
used in binding studies to determine binding specificity.
If later experiments confirm that PMSF is not an effective inhibitor against active
AaSPII or AaSPIV, the addition of other inhibitors can be used to both achieve purified
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inactive proteases and determine what type of inhibitors are effective against the
proteases, which would also provide insight into the enzyme function. Another method to
potentially inactivate the recombinant proteases expressed as MBP-fusion proteins would
be to include a reducing agent such as dithiothreitol (DTT) in the purification buffer to
counterbalance the effects of MBP as a solubility enhancer; expression with MBP could
assure that solubility of the recombinant proteases is achieved while reduction of the
disulfide bonds may be enough to minimize activity while maintaining solubility.
Purification efforts at lower pH values (Figures 34 and 35) implied the pH-dependence of
the proteases, which can be further explored to obtain pH profiles for each protease by
determining if autocatalyzation also occurs at higher pH values or if pH-dependence is
parallel to that of classic trypsin.
If the enzymes are autocatalyzing and potentially autodigesting, determining potential
internal cleavage sites within the active proteases would be extremely informative.
Cloning of the AaSPII and AaSPIV genes were both cloned into the pET29b vector,
which encodes for a C-terminal His6-tag. Further growth experiments will be performed
to determine the optimal conditions for producing soluble, recombinant enzyme with a
C-terminal His6-tag; if subsequent purification results also suggest autocatalytic behavior,
the cleaved protein product will still be purified by exploiting the His6-tag for IMAC.
Cleaved proteins and protein species could then be verified using N-terminal sequencing
and confirm specific internal cleavage sites, providing valuable information on potential
substrate recognition and specificity.
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